Granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
preferentially	O
activates	O
the	O
94-kD	B-protein
STAT5A	I-protein
and	O
an	O
80-kD	B-protein
STAT5A	I-protein
isoform	I-protein
in	O
human	O
peripheral	O
blood	O
monocytes	O
.	O

Granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
(	O
GM-CSF	B-protein
)	O
induces	O
immediate	O
effects	O
in	O
monocytes	O
by	O
activation	O
of	O
the	O
Janus	B-protein
kinase	I-protein
(	O
JAK2	B-protein
)	O
and	O
STAT	B-protein
transcription	I-protein
factor	I-protein
(	O
STAT5	B-protein
)	O
pathway	O
.	O

Recent	O
studies	O
have	O
identified	O
homologues	O
of	O
STAT5	B-protein
,	O
STAT5A	B-protein
,	O
and	O
STAT5B	B-protein
,	O
as	O
well	O
as	O
lower	O
molecular	O
weight	O
variants	O
of	O
STAT5	B-protein
.	O

To	O
define	O
the	O
activation	O
of	O
the	O
STAT5	B-protein
homologues	I-protein
and	O
lower	O
molecular	O
weight	O
variant	O
in	O
human	B-cell_type
monocytes	I-cell_type
and	O
monocytes	B-cell_type
differentiated	O
into	O
macrophages	B-cell_type
by	O
culture	O
in	O
macrophage-CSF	B-protein
(	O
M-CSF	B-protein
)	O
,	O
we	O
measured	O
the	O
GM-CSF	B-protein
induced	O
tyrosine	O
phosphorylation	O
of	O
STAT5A	B-protein
,	O
STAT5B	B-protein
,	O
and	O
any	O
lower	O
molecular	O
weight	O
STAT5	B-protein
isoforms	I-protein
.	O

Freshly	O
isolated	O
monocytes	O
expressed	O
94-kD	B-protein
STAT5A	I-protein
,	O
92-kD	O
STAT5B	B-protein
,	O
and	O
an	O
80-kD	B-protein
STAT5A	I-protein
molecule	I-protein
.	O

Whereas	O
94-kD	B-protein
STAT5A	I-protein
was	O
clearly	O
tyrosine	O
phosphorylated	O
and	O
bound	O
to	O
the	O
enhancer	B-DNA
element	I-DNA
,	O
the	O
gamma	B-DNA
response	I-DNA
region	I-DNA
(	O
GRR	B-DNA
)	O
,	O
of	O
the	O
Fc	B-DNA
gamma	I-DNA
RI	I-DNA
gene	I-DNA
,	O
substantially	O
less	O
tyrosine	O
phosphorylated	O
STAT5B	B-protein
bound	O
to	O
the	O
immobilized	O
GRR	B-DNA
element	I-DNA
.	O

Macrophages	O
lost	O
their	O
ability	O
to	O
express	O
the	O
80-kD	B-protein
STAT5A	I-protein
protein	I-protein
,	O
but	O
retained	O
their	O
ability	O
to	O
activate	O
STAT5A	B-protein
.	O

STAT5A-STAT5A	B-protein
homodimers	I-protein
and	O
STAT5A-STAT5B	B-protein
heterodimers	I-protein
formed	O
in	O
response	O
to	O
GM-CSF	B-protein
.	O

Therefore	O
,	O
activation	O
of	O
STAT5A	B-protein
predominates	O
compared	O
to	O
STAT5B	B-protein
when	O
assayed	O
by	O
direct	O
immunoprecipitation	O
and	O
by	O
evaluation	O
of	O
bound	O
STATs	B-protein
to	O
immobilized	O
GRR	B-DNA
.	O

Selective	O
activation	O
of	O
STAT5	B-protein
homologues	I-protein
in	O
addition	O
to	O
generation	O
of	O
lower	O
molecular	O
isoforms	O
may	O
provide	O
specificity	O
and	O
control	O
to	O
genes	O
expressed	O
in	O
response	O
to	O
cytokines	B-protein
such	O
as	O
GM-CSF	B-protein
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Granulocyte-Macrophage	NULL
Colony-Stimulating	NULL
Factor	NULL
Preferentially	NULL
Activates	NULL
the	NULL
94-kD	NULL
STATSA	NULL
and	NULL
an	NULL
80-kD	NULL
STAT5S5A	NULL
Isoform	NULL
in	NULL
Human	NULL
Peripheral	NULL
Blood	NULL
Monocytes	NULL
By	NULL
Rachel	NULL
L.	NULL
Rosen	NULL
,	NULL
Karen	NULL
D.	NULL
Winestock	NULL
,	NULL
Greta	NULL
Chen	NULL
,	NULL
Xiewen	NULL
Liu	NULL
,	NULL
Lothar	NULL
Hennighausen	NULL
,	NULL
and	NULL
David	NULL
S.	NULL
Finbloom	NULL
Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
induces	NULL
immediate	NULL
effects	NULL
in	NULL
monocytes	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
Janus	NULL
kinase	NULL
(	NULL
JAK2	NULL
)	NULL
and	NULL
STAT	NULL
transcription	NULL
factor	NULL
(	NULL
STATS	NULL
)	NULL
pathway	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
identified	NULL
homologues	NULL
of	NULL
STATS	NULL
,	NULL
STAT5A	NULL
,	NULL
and	NULL
STATSB	NULL
,	NULL
as	NULL
well	NULL
as	NULL
lower	NULL
molecular	NULL
weight	NULL
variants	NULL
of	NULL
STATS	NULL
.	NULL

To	NULL
define	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
STAT5	NULL
homologues	NULL
and	NULL
lower	NULL
molecular	NULL
weight	NULL
variant	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
monocytes	NULL
differentiated	NULL
into	NULL
macrophages	NULL
by	NULL
culture	NULL
in	NULL
macrophage-CSF	NULL
(	NULL
M-CSF	NULL
}	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
GM-CSF	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
,	NULL
STATSB	NULL
,	NULL
and	NULL
any	NULL
lower	NULL
molecular	NULL
weight	NULL
STAT5	NULL
isoforms	NULL
.	NULL

Freshly	NULL
isolated	NULL
monocytes	NULL
expressed	NULL
94-kD	NULL
STATS5A	NULL
,	NULL
92-kD	NULL
STAT5B	NULL
,	NULL
and	NULL
an	NULL
80-kD	NULL
STAT5A	NULL
molecule	NULL
.	NULL

Whereas	NULL
94-kD	NULL
STAT5A	NULL
was	NULL
clearly	NULL
tyrosine	NULL
phosphorylated	NULL
and	NULL
bound	NULL
to	NULL
the	NULL
enhancer	NULL
element	NULL
,	NULL
the	NULL
gamma	NULL
response	NULL
HE	NULL
RESPONSES	NULL
OF	NULL
monocytes	NULL
to	NULL
growth	NULL
factors	NULL
such	NULL
as	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
not	NULL
only	NULL
develop	NULL
over	NULL
days	NULL
for	NULL
actions	NULL
such	NULL
as	NULL
activation	NULL
and	NULL
differentiation	NULL
but	NULL
can	NULL
also	NULL
occur	NULL
rapidly	NULL
,	NULL
as	NULL
is	NULL
observed	NULL
for	NULL
signal	NULL
transduction	NULL
events	NULL
leading	NULL
to	NULL
immedi-ate	NULL
,	NULL
early	NULL
gene	NULL
expression	NULL
.	NULL

GM-CSF	NULL
treatment	NULL
of	NULL
monocytes	NULL
initiates	NULL
a	NULL
rapid	NULL
cascade	NULL
of	NULL
events	NULL
that	NULL
results	NULL
in	NULL
tyrosine	NULL
kinase	NULL
(	NULL
JAK2	NULL
)	NULL
activation	NULL
and	NULL
the	NULL
binding	NULL
of	NULL
latent	NULL
transcription	NULL
factors	NULL
to	NULL
specific	NULL
DNA	NULL
elements	NULL
.	NULL
``	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
exposure	NULL
of	NULL
monocytes	NULL
to	NULL
GM-CSF	NULL
results	NULL
in	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
DNA	NULL
binding	NULL
factor	NULL
that	NULL
recognizes	NULL
the	NULL
gamma	NULL
activation	NULL
sequence	NULL
(	NULL
GAS	NULL
)	NULL
or	NULL
gamma	NULL
response	NULL
region	NULL
(	NULL
GRR	NULL
)	NULL
element	NULL
.	NULL

!	NULL

This	NULL
factor	NULL
was	NULL
not	NULL
related	NULL
to	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transduction	NULL
1	NULL
(	NULL
STAT1	NULL
)	NULL
and	NULL
was	NULL
suggested	NULL
by	NULL
us	NULL
to	NULL
be	NULL
related	NULL
to	NULL
the	NULL
STAT	NULL
family	NULL
.	NULL

It	NULL
has	NULL
now	NULL
been	NULL
shown	NULL
that	NULL
GM-CSF	NULL
,	NULL
like	NULL
interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
,	NULL
can	NULL
activate	NULL
a	NULL
STAT	NULL
protein	NULL
originally	NULL
referred	NULL
to	NULL
as	NULL
mammary	NULL
gland	NULL
factor	NULL
,	NULL
a	NULL
protein	NULL
that	NULL
binds	NULL
an	NULL
element	NULL
similar	NULL
to	NULL
the	NULL
GRR	NULL
located	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
casein	NULL
milk	NULL
gene	NULL
.	NULL
``	NULL

This	NULL
factor	NULL
is	NULL
now	NULL
referred	NULL
to	NULL
as	NULL
STATS	NULL
.	NULL
``	NULL

STATS	NULL
is	NULL
also	NULL
activated	NULL
by	NULL
IL-2	NULL
,	NULL
IL-2-like	NULL
cytokines	NULL
such	NULL
as	NULL
IL-15	NULL
,	NULL
IL-3	NULL
,	NULL
IL-5	NULL
,	NULL
erythropoietin	NULL
,	NULL
and	NULL
thrombopoietin	NULL
``	NULL
~	NULL
and	NULL
can	NULL
bind	NULL
to	NULL
several	NULL
GAS	NULL
elements	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
STATS	NULL
seems	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
responses	NULL
observed	NULL
in	NULL
cells	NULL
of	NULL
hematopoietic	NULL
lineage	NULL
following	NULL
cytokine	NULL
stimulation	NULL
.	NULL

Unlike	NULL
the	NULL
other	NULL
STAT	NULL
proteins	NULL
,	NULL
STATS	NULL
consists	NULL
of	NULL
two	NULL
homologues	NULL
referred	NULL
to	NULL
as	NULL
STATSA	NULL
and	NULL
STATSB	NULL
.	NULL
``	NULL

''	NULL
``	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Cytokine	NULL
Biology	NULL
,	NULL
Center	NULL
for	NULL
Biologics	NULL
Research	NULL
and	NULL
Evaluation	NULL
,	NULL
Food	NULL
and	NULL
Drug	NULL
Administration	NULL
and	NULL
the	NULL
Laboratory	NULL
of	NULL
Biochemistry	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Diabetes	NULL
,	NULL
Digestive	NULL
,	NULL
and	NULL
Kidney	NULL
Diseases	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
.	NULL

Submitted	NULL
February	NULL
5	NULL
,	NULL
1996	NULL
;	NULL
accepted	NULL
April	NULL
1	NULL
,	NULL
1996	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
David	NULL
Finbloom	NULL
,	NULL
MD	NULL
,	NULL
Division	NULL
of	NULL
Cytokine	NULL
Biology	NULL
,	NULL
Food	NULL
and	NULL
Drug	NULL
Administration	NULL
,	NULL
HFM-505	NULL
,	NULL
29	NULL
Lincoln	NULL
Dr	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892-45555	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
'	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

This	NULL
is	NULL
a	NULL
US	NULL
government	NULL
work	NULL
.	NULL

There	NULL
are	NULL
no	NULL
restrictions	NULL
on	NULL
its	NULL
use	NULL
.	NULL

0006-497	NULL
1/96/8804-0002	NULL
$	NULL
0.00/0	NULL
1206	NULL
region	NULL
(	NULL
GRR	NULL
)	NULL
,	NULL
of	NULL
the	NULL
FoyRI	NULL
gene	NULL
,	NULL
substantially	NULL
less	NULL
tyrosine	NULL
phosphorylated	NULL
STAT5B	NULL
bound	NULL
to	NULL
the	NULL
immobilized	NULL
GRR	NULL
ele-ment	NULL
.	NULL

Macrophages	NULL
lost	NULL
their	NULL
ability	NULL
to	NULL
express	NULL
the	NULL
80-kD	NULL
STAT5A	NULL
protein	NULL
,	NULL
but	NULL
retained	NULL
their	NULL
ability	NULL
to	NULL
activate	NULL
STAT5A	NULL
.	NULL

STAT5A-STAT5A	NULL
homodimers	NULL
and	NULL
STAT5A-STAT5B	NULL
heterodimers	NULL
formed	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
.	NULL

Therefore	NULL
,	NULL
activation	NULL
of	NULL
STAT5A	NULL
predominates	NULL
compared	NULL
to	NULL
STAT5B	NULL
when	NULL
assayed	NULL
by	NULL
direct	NULL
immunoprecipitation	NULL
and	NULL
by	NULL
evaluation	NULL
of	NULL
bound	NULL
STATs	NULL
to	NULL
immobilized	NULL
GRR	NULL
.	NULL

Selective	NULL
activation	NULL
of	NULL
STATS	NULL
homologues	NULL
in	NULL
addition	NULL
to	NULL
generation	NULL
of	NULL
lower	NULL
molecular	NULL
isoforms	NULL
may	NULL
provide	NULL
specificity	NULL
and	NULL
control	NULL
to	NULL
genes	NULL
expressed	NULL
in	NULL
response	NULL
to	NULL
cytokines	NULL
such	NULL
as	NULL
GM-CSF	NULL
.	NULL

This	NULL
is	NULL
a	NULL
US	NULL
government	NULL
work	NULL
.	NULL

There	NULL
are	NULL
no	NULL
restrictions	NULL
on	NULL
its	NULL
use	NULL
.	NULL

These	NULL
two	NULL
proteins	NULL
are	NULL
expressed	NULL
from	NULL
two	NULL
different	NULL
but	NULL
highly	NULL
homologous	NULL
genes	NULL
and	NULL
have	NULL
a	NULL
molecular	NULL
weight	NULL
of	NULL
about	NULL
94	NULL
kD	NULL
(	NULL
STATSA	NULL
)	NULL
and	NULL
92	NULL
kD	NULL
(	NULL
STATS5B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
our	NULL
earlier	NULL
studies	NULL
,	NULL
the	NULL
GM-CSF-induced	NULL
,	NULL
tyrosine-phosphorylated	NULL
protein	NULL
was	NULL
shown	NULL
to	NULL
have	NULL
a	NULL
molecular	NULL
weight	NULL
of	NULL
about	NULL
80	NULL
kD	NULL
.	NULL
'	NULL

Because	NULL
at	NULL
that	NULL
time	NULL
STATS	NULL
was	NULL
as	NULL
yet	NULL
undiscovered	NULL
,	NULL
it	NULL
was	NULL
not	NULL
until	NULL
the	NULL
purification	NULL
of	NULL
an	NULL
IL-3-induced	NULL
DNA	NULL
binding	NULL
protein	NULL
that	NULL
an	NULL
80-kD	NULL
form	NULL
of	NULL
STATS5	NULL
was	NULL
appreciated	NULL
.	NULL
``	NULL

Indeed	NULL
,	NULL
in	NULL
that	NULL
study	NULL
,	NULL
no	NULL
full-length	NULL
protein	NULL
was	NULL
isolated	NULL
by	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
.	NULL

Very	NULL
recently	NULL
,	NULL
a	NULL
lower	NULL
molecular	NULL
weight	NULL
form	NULL
of	NULL
STATSB	NULL
was	NULL
found	NULL
in	NULL
murine	NULL
liver	NULL
in	NULL
response	NULL
to	NULL
injection	NULL
of	NULL
complete	NULL
Freund	NULL
's	NULL
adjuvant	NULL
,	NULL
but	NULL
the	NULL
functional	NULL
relevance	NULL
of	NULL
this	NULL
lower	NULL
molecular	NULL
weight	NULL
STATS5B	NULL
was	NULL
not	NULL
determined	NULL
.	NULL
``	NULL

Very	NULL
little	NULL
is	NULL
known	NULL
regarding	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
homologues	NULL
of	NULL
STATS	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
in	NULL
monocytes	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
role	NULL
that	NULL
differentiation	NULL
plays	NULL
on	NULL
the	NULL
response	NULL
of	NULL
macrophages	NULL
to	NULL
GM-CSF	NULL
as	NULL
measured	NULL
by	NULL
STATS	NULL
activation	NULL
is	NULL
unexplored	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
,	NULL
we	NULL
studied	NULL
freshly	NULL
isolated	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
and	NULL
compared	NULL
their	NULL
profile	NULL
of	NULL
STATS	NULL
activation	NULL
with	NULL
monocytes	NULL
that	NULL
were	NULL
cultured	NULL
in	NULL
macrophage-CSF	NULL
(	NULL
M-CSF	NULL
)	NULL
,	NULL
a	NULL
well-characterized	NULL
cytokine	NULL
that	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
and	NULL
differentiation	NULL
of	NULL
monocytes	NULL
into	NULL
macrophage-like	NULL
cells	NULL
.	NULL
``	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
.	NULL

-	NULL
Monocytes	NULL
were	NULL
obtained	NULL
as	NULL
a	NULL
leukopak	NULL
from	NULL
normal	NULL
volunteers	NULL
after	NULL
leukapheresis	NULL
.	NULL

The	NULL
mononuclear-enriched	NULL
population	NULL
of	NULL
cells	NULL
were	NULL
further	NULL
purified	NULL
by	NULL
Ficoll-Hypaque	NULL
(	NULL
LSM	NULL
;	NULL
Organon	NULL
Tecknica	NULL
,	NULL
Durham	NULL
,	NULL
NC	NULL
)	NULL
density	NULL
centrifugation	NULL
.	NULL

The	NULL
mononuclear	NULL
cells	NULL
,	NULL
consisting	NULL
of	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
,	NULL
were	NULL
then	NULL
separated	NULL
by	NULL
countercurrent	NULL
centrifugal	NULL
elutriation	NULL
in	NULL
a	NULL
Beckmann	NULL
J-6	NULL
centrifuge	NULL
fitted	NULL
with	NULL
an	NULL
elutriation	NULL
rotor	NULL
.	NULL

Monocytes	NULL
obtained	NULL
in	NULL
this	NULL
fashion	NULL
are	NULL
greater	NULL
than	NULL
95	NULL
%	NULL
pure	NULL
as	NULL
determined	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
analysis	NULL
with	NULL
anti-CD14	NULL
.	NULL

Monocytes	NULL
were	NULL
harvested	NULL
in	NULL
suspension	NULL
and	NULL
remained	NULL
so	NULL
throughout	NULL
the	NULL
experimental	NULL
procedures	NULL
that	NULL
used	NULL
fresh	NULL
monocytes	NULL
.	NULL

Macrophage-like	NULL
cells	NULL
were	NULL
generated	NULL
by	NULL
culturing	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
in	NULL
endotoxin-free	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
GIBCO	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
pooled	NULL
AB	NULL
human	NULL
serum	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
and	NULL
M-CSF	NULL
(	NULL
Genetics	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
at	NULL
100	NULL
ng/mL	NULL
for	NULL
4	NULL
to	NULL
6	NULL
days	NULL
,	NULL
at	NULL
which	NULL
time	NULL
they	NULL
become	NULL
enlarged	NULL
and	NULL
Blood	NULL
,	NULL
Vol	NULL
88	NULL
,	NULL
No	NULL
4	NULL
(	NULL
August	NULL
15	NULL
)	NULL
,	NULL
1996	NULL
:	NULL
pp	NULL
1206-1214	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

GM-CSF	NULL
ACTIVATION	NULL
OF	NULL
STAT5A	NULL
AND	NULL
STAT5B	NULL
somewhat	NULL
adherent	NULL
.	NULL

The	NULL
recovery	NULL
of	NULL
monocyte/macrophages	NULL
was	NULL
between	NULL
60	NULL
%	NULL
and	NULL
80	NULL
%	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
greater	NULL
than	NULL
99	NULL
%	NULL
viable	NULL
.	NULL

Immunoprecipitations	NULL
.	NULL

|	NULL
Fresh	NULL
.	NULL

monocytes	NULL
or	NULL
monocyte/macrophages	NULL
were	NULL
treated	NULL
with	NULL
GM-CSF	NULL
(	NULL
50	NULL
ng/mL	NULL
;	NULL
Schering	NULL
Plough	NULL
,	NULL
Kenilworth	NULL
,	NULL
NJ	NULL
)	NULL
for	NULL
various	NULL
times	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
solubilized	NULL
in	NULL
a	NULL
buffer	NULL
consisting	NULL
of	NULL
1	NULL
%	NULL
TX100	NULL
(	NULL
Piece	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
,	NULL
0.15	NULL
mol/L	NULL
NaCl	NULL
,	NULL
50	NULL
mmol/L	NULL
NaF	NULL
,	NULL
5	NULL
mmol/L	NULL
sodium	NULL
pyrophos-phate	NULL
,	NULL
1	NULL
mmol/L	NULL
vanadate	NULL
,	NULL
and	NULL
5	NULL
pg/mL	NULL
each	NULL
of	NULL
leupeptin	NULL
,	NULL
pepstatin	NULL
,	NULL
and	NULL
aprotinin	NULL
.	NULL

For	NULL
some	NULL
immunoprecipitations	NULL
,	NULL
additional	NULL
NaC	NULL
)	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.25	NULL
mol/L	NULL
.	NULL

The	NULL
extract	NULL
was	NULL
centrifuged	NULL
at	NULL
18,000g	NULL
for	NULL
I0	NULL
minutes	NULL
and	NULL
the	NULL
postnuclear	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
desired	NULL
antibodies	NULL
.	NULL

Anti-STATS5	NULL
was	NULL
produced	NULL
in	NULL
rabbits	NULL
using	NULL
a	NULL
peptide	NULL
consisting	NULL
of	NULL
the	NULL
COOH	NULL
terminal	NULL
50	NULL
amino	NULL
acids	NULL
of	NULL
which	NULL
the	NULL
first	NULL
30	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
peptide	NULL
were	NULL
about	NULL
75	NULL
%	NULL
homologous	NULL
for	NULL
both	NULL
STATSA	NULL
and	NULL
STATS5B	NULL
.	NULL

*	NULL
``	NULL
``	NULL
Anti-STATS5A	NULL
and	NULL
anti-STATSB	NULL
were	NULL
produced	NULL
in	NULL
rabbits	NULL
using	NULL
the	NULL
20	NULL
COOH	NULL
terminal	NULL
amino	NULL
acids	NULL
unique	NULL
to	NULL
STAT5A	NULL
and	NULL
the	NULL
11	NULL
COOH	NULL
terminal	NULL
amino	NULL
acids	NULL
unique	NULL
to	NULL
STATS5B	NULL
,	NULL
respectively	NULL
.	NULL
``	NULL

''	NULL
There	NULL
was	NULL
no	NULL
cross-reactivity	NULL
of	NULL
the	NULL
anti-STATSA	NULL
and	NULL
anti-STATSB	NULL
antibodies	NULL
.	NULL

The	NULL
anti-STATS	NULL
antibody	NULL
recognized	NULL
both	NULL
STATS5SA	NULL
and	NULL
STAT5B	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
isolated	NULL
with	NULL
Sepharose-protein	NULL
G	NULL
(	NULL
Phar-macia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
,	NULL
released	NULL
in	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
sample	NULL
buffer	NULL
,	NULL
and	NULL
electrophoresed	NULL
on	NULL
7.5	NULL
%	NULL
minigels	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
8	NULL
%	NULL
standard	NULL
15-cm	NULL
gels	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
polyvinyldipyrolidine	NULL
fluoride	NULL
(	NULL
PVDF	NULL
)	NULL
membranes	NULL
(	NULL
Milli-pore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
antibodies	NULL
(	NULL
PY20	NULL
;	NULL
Leinco	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
and	NULL
developed	NULL
using	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
;	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

For	NULL
some	NULL
experiments	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
reprobed	NULL
with	NULL
the	NULL
immunoprecipitating	NULL
antibody	NULL
or	NULL
another	NULL
antibody	NULL
and	NULL
developed	NULL
after	NULL
incubation	NULL
with	NULL
an	NULL
alkaline	NULL
phosphatase	NULL
anti-Ig	NULL
with	NULL
nitroblue	NULL
tetrazo-lium	NULL
(	NULL
NBT	NULL
)	NULL
chemistry	NULL
.	NULL

DNA	NULL
affinity	NULL
purification	NULL
.	NULL

-	NULL
The	NULL
upper	NULL
strand	NULL
of	NULL
the	NULL
GRR	NULL
element	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
FeyRI	NULL
receptor	NULL
was	NULL
synthesized	NULL
with	NULL
a	NULL
biotinylated	NULL
BamHI	NULL
overhang	NULL
.	NULL

The	NULL
lower	NULL
stand	NULL
was	NULL
synthesized	NULL
with	NULL
the	NULL
BamHI	NULL
overhang	NULL
but	NULL
without	NULL
the	NULL
biotinylated	NULL
base	NULL
.	NULL

Each	NULL
oligonucle-otide	NULL
was	NULL
purified	NULL
by	NULL
urea/denaturing	NULL
gel	NULL
electrophoresis	NULL
and	NULL
then	NULL
annealed	NULL
in	NULL
0.1	NULL
mol/L	NULL
NaCl	NULL
.	NULL

The	NULL
annealed	NULL
biotinylated	NULL
GRR	NULL
probe	NULL
was	NULL
then	NULL
incubated	NULL
with	NULL
Sepharose-avidin	NULL
(	NULL
Sigma	NULL
)	NULL
at	NULL
a	NULL
ratio	NULL
to	NULL
yield	NULL
maximal	NULL
saturation	NULL
of	NULL
the	NULL
Sepharose	NULL
with	NULL
the	NULL
DNA	NULL
.	NULL

For	NULL
the	NULL
GRR-sepharose	NULL
precipitations	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
GM-CSF	NULL
for	NULL
various	NULL
times	NULL
at	NULL
37°C	NULL
and	NULL
solubilized	NULL
in	NULL
whole	NULL
cell	NULL
extraction	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
pH	NULL
7.3	NULL
,	NULL
400	NULL
mmol/L	NULL
KCI	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
mmol/	NULL
L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
0.1	NULL
%	NULL
TX100	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
1	NULL
mmol/	NULL
L	NULL
vanadate	NULL
,	NULL
and	NULL
protein	NULL
inhibitors	NULL
as	NULL
previously	NULL
described	NULL
)	NULL
.	NULL

The	NULL
GRR-sepharose	NULL
was	NULL
incubated	NULL
for	NULL
1	NULL
to	NULL
2	NULL
hours	NULL
at	NULL
4°C	NULL
in	NULL
the	NULL
extract	NULL
after	NULL
the	NULL
salt	NULL
was	NULL
diluted	NULL
to	NULL
133	NULL
mmol/L	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
washed	NULL
in	NULL
whole	NULL
cell	NULL
lysis	NULL
buffer	NULL
with	NULL
60	NULL
mmol/L	NULL
KCI	NULL
,	NULL
and	NULL
the	NULL
bound	NULL
proteins	NULL
were	NULL
released	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
the	NULL
anti-STAT	NULL
or	NULL
antiphosphotyrosine	NULL
antibodies	NULL
.	NULL

RESULTS	NULL
Activation	NULL
of	NULL
STATS	NULL
in	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
.	NULL

-	NULL
Monocytes	NULL
,	NULL
isolated	NULL
in	NULL
suspension	NULL
by	NULL
elutriation	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
GM-CSF	NULL
,	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
STATS	NULL
was	NULL
determined	NULL
.	NULL

Immunoprecipitated	NULL
STATS	NULL
was	NULL
tyrosine-phosphorylated	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
(	NULL
Fig	NULL
1A	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Tyrosine-phosphorylated	NULL
,	NULL
immunoprecipitated	NULL
STATS	NULL
was	NULL
also	NULL
observed	NULL
using	NULL
antibodies	NULL
against	NULL
STATSA	NULL
(	NULL
Fig	NULL
1A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
and	NULL
STATSB	NULL
(	NULL
Fig	NULL
1A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Only	NULL
the	NULL
full-length	NULL
STATS	NULL
molecules	NULL
(	NULL
94/92	NULL
kD	NULL
)	NULL
were	NULL
observed	NULL
to	NULL
be	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
fresh	NULL
monocytes	NULL
despite	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
80-kD	NULL
protein	NULL
was	NULL
present	NULL
in	NULL
the	NULL
immunoprecipi-	NULL
1207	NULL
tates	NULL
as	NULL
determined	NULL
by	NULL
reprobing	NULL
of	NULL
the	NULL
membrane	NULL
with	NULL
the	NULL
immunoprecipitating	NULL
antibodies	NULL
(	NULL
Fig	NULL
1B	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Only	NULL
in	NULL
the	NULL
anti-STAT5A	NULL
immunoprecipitate	NULL
was	NULL
the	NULL
80kD	NULL
protein	NULL
observed	NULL
,	NULL
suggesting	NULL
that	NULL
,	NULL
in	NULL
monocytes	NULL
,	NULL
STAT5SA	NULL
(	NULL
Fig	NULL
1B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
STATSB	NULL
(	NULL
Fig	NULL
1B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
existed	NULL
as	NULL
a	NULL
lower	NULL
molecular	NULL
weight	NULL
form	NULL
.	NULL

In	NULL
nonmyeloid	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
T-cell	NULL
blasts	NULL
,	NULL
no	NULL
80-kD	NULL
band	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
1B	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
T-cell	NULL
blasts	NULL
,	NULL
the	NULL
ability	NULL
to	NULL
activate	NULL
STATS	NULL
(	NULL
Fig	NULL
1A	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
;	NULL
and	NULL
thereby	NULL
STATS-dependent	NULL
genes	NULL
)	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
appeared	NULL
to	NULL
require	NULL
only	NULL
full-length	NULL
STATS	NULL
proteins	NULL
.	NULL

When	NULL
extracts	NULL
from	NULL
fresh	NULL
monocytes	NULL
that	NULL
had	NULL
been	NULL
exposed	NULL
to	NULL
GM-CSF	NULL
were	NULL
incubated	NULL
with	NULL
Sepharose-GRR	NULL
,	NULL
additional	NULL
information	NULL
regarding	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
STATS	NULL
DNA	NULL
binding	NULL
complex	NULL
was	NULL
shown	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
immunoprecipitations	NULL
in	NULL
which	NULL
essentially	NULL
no	NULL
tyrosine-phosphorylated	NULL
80-kD	NULL
STATS	NULL
was	NULL
observed	NULL
,	NULL
there	NULL
was	NULL
a	NULL
moderate	NULL
amount	NULL
of	NULL
the	NULL
80-kD	NULL
STATS	NULL
that	NULL
was	NULL
clearly	NULL
bound	NULL
to	NULL
the	NULL
GRR	NULL
element	NULL
(	NULL
Fig	NULL
2A	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
.	NULL

This	NULL
was	NULL
observed	NULL
when	NULL
both	NULL
the	NULL
anti-STAT5	NULL
(	NULL
Fig	NULL
2A	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
and	NULL
anti-STATSA	NULL
(	NULL
Fig	NULL
2A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
were	NULL
used	NULL
to	NULL
probe	NULL
the	NULL
membrane	NULL
containing	NULL
the	NULL
GRR-Sepharose	NULL
isolated	NULL
proteins	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
80-kD	NULL
band	NULL
was	NULL
observed	NULL
bound	NULL
to	NULL
the	NULL
GRR	NULL
element	NULL
when	NULL
the	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
the	NULL
anti-STATS5B	NULL
(	NULL
Fig	NULL
2A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
confirmed	NULL
that	NULL
the	NULL
80-kD	NULL
protein	NULL
observed	NULL
in	NULL
fresh	NULL
monocytes	NULL
was	NULL
predominantly	NULL
STATS5A	NULL
or	NULL
antigenically	NULL
related	NULL
to	NULL
STATSA	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
80-kD	NULL
protein	NULL
bound	NULL
to	NULL
the	NULL
GRR-Sepha-rose	NULL
,	NULL
the	NULL
94/92-kD	NULL
STATS	NULL
proteins	NULL
were	NULL
also	NULL
observed	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
bands	NULL
on	NULL
the	NULL
immunoblot	NULL
suggested	NULL
that	NULL
much	NULL
more	NULL
STATSA	NULL
than	NULL
STATSB	NULL
was	NULL
bound	NULL
to	NULL
the	NULL
GRR	NULL
element	NULL
(	NULL
Fig	NULL
2A	NULL
,	NULL
lane	NULL
2	NULL
v	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

When	NULL
the	NULL
membranes	NULL
in	NULL
Fig	NULL
2A	NULL
were	NULL
reprobed	NULL
with	NULL
antiphosphotyrosine	NULL
antibodies	NULL
,	NULL
both	NULL
the	NULL
94/92-kD	NULL
(	NULL
Fig	NULL
2B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
and	NULL
the	NULL
80-kD	NULL
proteins	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
tyrosine-phosphorylated	NULL
(	NULL
Figure	NULL
2B	NULL
,	NULL
lanes	NULL
2	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
STAT1	NULL
present	NULL
on	NULL
immunoblots	NULL
containing	NULL
GM-CSF-activated	NULL
,	NULL
GRR-bound	NULL
proteins	NULL
(	NULL
D.	NULL
Finbloom	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
GM-CSF-activated	NULL
GRR	NULL
binding	NULL
activity	NULL
as	NULL
measured	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
could	NULL
not	NULL
be	NULL
``	NULL
supershifted	NULL
'	NULL
``	NULL
``	NULL
with	NULL
anti-STAT1	NULL
antibody	NULL
.	NULL
'	NULL

Activation	NULL
of	NULL
STATS	NULL
in	NULL
monocyte/macrophages	NULL
.	NULL

-	NULL
When	NULL
monocytes	NULL
were	NULL
cultured	NULL
in	NULL
M-CSF	NULL
for	NULL
several	NULL
days	NULL
,	NULL
the	NULL
cells	NULL
enlarged	NULL
and	NULL
acquired	NULL
characteristics	NULL
of	NULL
tissue	NULL
macro-phages	NULL
.	NULL
``	NULL

When	NULL
these	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
GM-CSF	NULL
,	NULL
STATS	NULL
was	NULL
activated	NULL
as	NULL
determined	NULL
by	NULL
its	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lanes	NULL
1	NULL
through	NULL
6	NULL
)	NULL
.	NULL

When	NULL
the	NULL
extracts	NULL
of	NULL
cells	NULL
exposed	NULL
to	NULL
GM-CSF	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-STAT5SA	NULL
and	NULL
anti-STAT5B	NULL
,	NULL
there	NULL
was	NULL
an	NULL
intense	NULL
band	NULL
at	NULL
94/92	NULL
kD	NULL
of	NULL
essentially	NULL
equal	NULL
intensity	NULL
for	NULL
the	NULL
two	NULL
homologues	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lanes	NULL
1	NULL
through	NULL
4	NULL
)	NULL
.	NULL

A	NULL
band	NULL
of	NULL
similar	NULL
mobility	NULL
but	NULL
of	NULL
lesser	NULL
intensity	NULL
was	NULL
observed	NULL
when	NULL
the	NULL
cell	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-STATS	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
as	NULL
with	NULL
fresh	NULL
monocytes	NULL
,	NULL
no	NULL
80-kD	NULL
tyrosine-phosphorylated	NULL
protein	NULL
was	NULL
immunoprecipitated	NULL
by	NULL
the	NULL
antibodies	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
fresh	NULL
monocytes	NULL
,	NULL
when	NULL
the	NULL
membrane	NULL
from	NULL
the	NULL
anti-STATS5	NULL
immunoprecipitations	NULL
from	NULL
the	NULL
macrophages	NULL
was	NULL
reprobed	NULL
with	NULL
anti-STATS5	NULL
,	NULL
only	NULL
the	NULL
92/	NULL
94-kD	NULL
doublet	NULL
was	NULL
noted	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

No	NULL
80-kD	NULL
protein	NULL
was	NULL
observed	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1208	NULL
IP	NULL
:	NULL
Anti-	NULL
5A	NULL
5B	NULL
Blot	NULL
:	NULL
Anti-STAT5	NULL
Anti-phosphotyrosine	NULL
Control	NULL
GMCSF	NULL
Control	NULL
GMCSF	NULL
94/92kD	NULL
-	NULL
»	NULL
ID	NULL
G	NULL
Blot	NULL
:	NULL
Anti-	NULL
5A	NULL
5B	NULL
94/92kD	NULL
_	NULL
,	NULL
8OkKD	NULL
-*	NULL
Anti-STATS	NULL
can	NULL
Lie	NULL
(	NULL
t	NULL
Gi	NULL
,	NULL
5	NULL
6	NULL
7	NULL
8	NULL
§k-1	NULL
1	NULL
2	NULL
3	NULL
4	NULL
obtained	NULL
from	NULL
membranes	NULL
of	NULL
the	NULL
anti-STATSA	NULL
and	NULL
STATSB	NULL
immunoblots	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
next	NULL
exposed	NULL
monocytes	NULL
cultured	NULL
in	NULL
M-CSF	NULL
to	NULL
GMCSF	NULL
and	NULL
then	NULL
solubilized	NULL
the	NULL
cells	NULL
in	NULL
whole	NULL
cell	NULL
lysis	NULL
buffer	NULL
for	NULL
isolation	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
on	NULL
the	NULL
Sepharose-GRR	NULL
.	NULL

In	NULL
response	NULL
to	NULL
GM-CSF	NULL
,	NULL
both	NULL
STATSA	NULL
and	NULL
STATSB	NULL
were	NULL
observed	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
GRR	NULL
element	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
lanes	NULL
1	NULL
through	NULL
4	NULL
)	NULL
.	NULL

As	NULL
was	NULL
observed	NULL
with	NULL
fresh	NULL
monocytes	NULL
,	NULL
more	NULL
STATSA	NULL
bound	NULL
to	NULL
the	NULL
GRR	NULL
when	NULL
compared	NULL
with	NULL
STATSB	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
lane	NULL
2	NULL
v	NULL
4	NULL
)	NULL
.	NULL

When	NULL
similar	NULL
membranes	NULL
containing	NULL
STATSA	NULL
and	NULL
STATSB	NULL
from	NULL
GRR	NULL
precipitations	NULL
from	NULL
other	NULL
experiments	NULL
were	NULL
probed	NULL
for	NULL
antiphosphotyrosine	NULL
,	NULL
there	NULL
was	NULL
substantially	NULL
less	NULL
tyrosine-phosphorylated	NULL
STATSB	NULL
compared	NULL
with	NULL
STATSA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

On	NULL
close	NULL
observation	NULL
of	NULL
the	NULL
membrane	NULL
probed	NULL
with	NULL
anti-STATS	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
there	NULL
was	NULL
a	NULL
doublet	NULL
at	NULL
the	NULL
94/92-kD	NULL
region	NULL
.	NULL

The	NULL
lower	NULL
band	NULL
,	NULL
presumably	NULL
STATSB	NULL
,	NULL
was	NULL
much	NULL
weaker	NULL
in	NULL
intensity	NULL
than	NULL
the	NULL
upper	NULL
(	NULL
STATSA	NULL
)	NULL
band	NULL
.	NULL

When	NULL
this	NULL
membrane	NULL
was	NULL
reprobed	NULL
for	NULL
antiphosphotyrosine	NULL
,	NULL
only	NULL
the	NULL
upper	NULL
or	NULL
94-kD	NULL
band	NULL
was	NULL
observed	NULL
to	NULL
be	NULL
tyrosine-phosphorylated	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
there	NULL
may	NULL
be	NULL
preferential	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STATSA	NULL
in	NULL
response	NULL
to	NULL
GMCSF	NULL
in	NULL
this	NULL
monocyte/macrophage	NULL
population	NULL
.	NULL

Kinetics	NULL
of	NULL
activation	NULL
of	NULL
STAT53	NULL
.	NULL

We	NULL
next	NULL
explored	NULL
the	NULL
rate	NULL
of	NULL
activation	NULL
of	NULL
STATSA	NULL
and	NULL
STATSB	NULL
in	NULL
fresh	NULL
monocytes	NULL
.	NULL

Preliminary	NULL
experiments	NULL
using	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
with	NULL
the	NULL
GRR	NULL
probe	NULL
showed	NULL
that	NULL
activation	NULL
of	NULL
GRR	NULL
binding	NULL
occurred	NULL
within	NULL
5	NULL
minutes	NULL
and	NULL
persisted	NULL
for	NULL
up	NULL
to	NULL
45	NULL
minutes	NULL
,	NULL
after	NULL
which	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
shifted	NULL
band	NULL
decreased	NULL
(	NULL
G.	NULL
Chen	NULL
and	NULL
D.	NULL
Finbloom	NULL
,	NULL
unpublished	NULL
ob	NULL
a=	NULL
as	NULL
as	NULL
as	NULL
<	NULL
-f	NULL
*-	NULL
BOkD	NULL
ROSEN	NULL
ET	NULL
AL	NULL
Fig	NULL
1	NULL
.	NULL

STATS	NULL
activation	NULL
by	NULL
GM-CSF	NULL
in	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Fresh	NULL
monocytes	NULL
(	NULL
lanes	NULL
1	NULL
through	NULL
6	NULL
)	NULL
were	NULL
exposed	NULL
to	NULL
GM-CSF	NULL
at	NULL
50	NULL
ng/mL	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
37°C	NULL
and	NULL
then	NULL
solubilized	NULL
for	NULL
immunoprecipitation	NULL
of	NULL
STATS	NULL
proteins	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
(	NULL
anti-STAT5A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
;	NULL
anti-STAT5B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
;	NULL
and	NULL
anti-STAT5	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
were	NULL
isolated	NULL
on	NULL
7.5	NULL
%	NULL
SDS-PAGE	NULL
minigels	NULL
and	NULL
transferred	NULL
to	NULL
PVDF	NULL
,	NULL
and	NULL
the	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
and	NULL
developed	NULL
using	NULL
ECL	NULL
.	NULL

For	NULL
comparison	NULL
,	NULL
T-cell	NULL
blasts	NULL
were	NULL
treated	NULL
with	NULL
IL-2	NULL
and	NULL
solubilized	NULL
,	NULL
and	NULL
STATS	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
anti-STATS5	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
membrane	NULL
shown	NULL
in	NULL
(	NULL
A	NULL
)	NULL
was	NULL
reprobed	NULL
with	NULL
the	NULL
immunoprecipitating	NULL
antibody	NULL
and	NULL
developed	NULL
using	NULL
alkaline	NULL
phosphatase	NULL
and	NULL
NBT	NULL
chemistry	NULL
.	NULL

servations	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
noted	NULL
that	NULL
GRR	NULL
binding	NULL
activity	NULL
was	NULL
recovered	NULL
to	NULL
a	NULL
greater	NULL
extent	NULL
from	NULL
nuclear	NULL
extracts	NULL
as	NULL
compared	NULL
with	NULL
cytoplasmic	NULL
extracts	NULL
,	NULL
suggesting	NULL
that	NULL
there	NULL
was	NULL
rapid	NULL
translocation	NULL
of	NULL
the	NULL
activated	NULL
STATS	NULL
complex	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

We	NULL
explored	NULL
the	NULL
kinetics	NULL
of	NULL
activation	NULL
by	NULL
both	NULL
immunoprecipitation	NULL
with	NULL
anti-STATSA	NULL
and	NULL
anti-STATS5B	NULL
antibodies	NULL
and	NULL
by	NULL
precipitation	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
complex	NULL
with	NULL
GRR	NULL
agarose	NULL
.	NULL

Activation	NULL
of	NULL
both	NULL
STATSA	NULL
and	NULL
STATSB	NULL
occurred	NULL
within	NULL
5	NULL
minutes	NULL
after	NULL
treatment	NULL
with	NULL
GM-CSF	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lanes	NULL
1	NULL
through	NULL
5	NULL
)	NULL
.	NULL

Maximal	NULL
tyrosine	NULL
phosphorylation	NULL
for	NULL
immunoprecipitated	NULL
STATSA	NULL
and	NULL
STATSB	NULL
was	NULL
at	NULL
5	NULL
to	NULL
15	NULL
minutes	NULL
.	NULL

At	NULL
60	NULL
minutes	NULL
there	NULL
was	NULL
still	NULL
readily	NULL
observable	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
STATS	NULL
isoforms	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
activation	NULL
were	NULL
somewhat	NULL
different	NULL
for	NULL
STATS	NULL
subjected	NULL
to	NULL
GRR	NULL
precipitation	NULL
(	NULL
Fig	NULL
5B	NULL
,	NULL
lanes	NULL
1	NULL
through	NULL
5	NULL
)	NULL
.	NULL

Maximal	NULL
binding	NULL
to	NULL
the	NULL
GRR	NULL
agarose	NULL
occurred	NULL
at	NULL
15	NULL
to	NULL
30	NULL
minutes	NULL
,	NULL
and	NULL
even	NULL
at	NULL
90	NULL
minutes	NULL
considerable	NULL
GRR	NULL
binding	NULL
activity	NULL
remained	NULL
.	NULL

The	NULL
kinetics	NULL
were	NULL
similar	NULL
for	NULL
both	NULL
STATSA	NULL
and	NULL
STATSB	NULL
.	NULL

These	NULL
data	NULL
confirm	NULL
the	NULL
preliminary	NULL
gel	NULL
shift	NULL
data	NULL
by	NULL
suggesting	NULL
that	NULL
translocation	NULL
of	NULL
the	NULL
activated	NULL
STATS	NULL
molecules	NULL
begins	NULL
to	NULL
occur	NULL
shortly	NULL
after	NULL
activation	NULL
.	NULL

STATS	NULL
homodimer	NULL
and	NULL
heterodimer	NULL
formation	NULL
.	NULL

It	NULL
has	NULL
been	NULL
well-documented	NULL
for	NULL
many	NULL
cytokines	NULL
that	NULL
activate	NULL
STAT	NULL
proteins	NULL
that	NULL
both	NULL
homodimer	NULL
and	NULL
heterodimer	NULL
formation	NULL
occurs	NULL
between	NULL
various	NULL
STAT	NULL
proteins	NULL
in	NULL
response	NULL
to	NULL
cytokine	NULL
stimulation	NULL
.	NULL

'*	NULL
To	NULL
assess	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
tyrosine-phosphorylated	NULL
band	NULL
observed	NULL
in	NULL
the	NULL
STAT	NULL
5B	NULL
immunoprecipitations	NULL
was	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
if	NULL
not	NULL
predominantly	NULL
,	NULL
because	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
STAT5SA	NULL
within	NULL
a	NULL
heterodimer	NULL
,	NULL
we	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

GM-CSF	NULL
ACTIVATION	NULL
OF	NULL
STAT5SA	NULL
AND	NULL
STATSB	NULL
A	NULL
Pptn	NULL
:	NULL
Blot	NULL
:	NULL
Anti-	NULL
5A	NULL
5B	NULL
94/92kD	NULL
_	NULL
.	NULL

80OkD	NULL
~*	NULL
B	NULL
Fig	NULL
2	NULL
.	NULL

STATS	NULL
bound	NULL
to	NULL
the	NULL
GRR	NULL
element	NULL
in	NULL
GM-CSF-treated	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Freshly	NULL
isolated	NULL
monocytes	NULL
were	NULL
treated	NULL
as	NULL
in	NULL
Fig	NULL
1	NULL
with	NULL
GM-CSF	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
whole	NULL
cell	NULL
lysis	NULL
buffer	NULL
and	NULL
the	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
GRR-Sepharose	NULL
.	NULL

The	NULL
bound	NULL
proteins	NULL
were	NULL
released	NULL
in	NULL
SDS	NULL
,	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
PVDF	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
anti-STAT5A	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
anti-STATS5B	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
and	NULL
anti-STATS	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
and	NULL
developed	NULL
using	NULL
ECL	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
same	NULL
membrane	NULL
was	NULL
reprobed	NULL
with	NULL
antiphosphotyrosine	NULL
antibodies	NULL
and	NULL
developed	NULL
using	NULL
alkaline	NULL
phosphatase	NULL
and	NULL
NBT	NULL
chemistry	NULL
.	NULL

Blot	NULL
performed	NULL
``	NULL
crossed	NULL
immunoprecipitation	NULL
``	NULL
experiments	NULL
in	NULL
which	NULL
extracts	NULL
of	NULL
cells	NULL
exposed	NULL
to	NULL
GM-CSF	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-STATSA	NULL
or	NULL
anti-STATSB	NULL
and	NULL
then	NULL
the	NULL
resulting	NULL
membrane	NULL
was	NULL
immunoblotted	NULL
with	NULL
anti-STATSB	NULL
or	NULL
anti-STATSA	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
fresh	NULL
monocytes	NULL
,	NULL
immunoprecipitation	NULL
with	NULL
anti-STAT5A	NULL
resulted	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
only	NULL
STATSA	NULL
in	NULL
the	NULL
immunoprecipitate	NULL
(	NULL
Fig	NULL
6A	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
.	NULL

No	NULL
STATS5B	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
anti-STAT5A	NULL
immunoprecipitate	NULL
.	NULL

The	NULL
negative	NULL
staining	NULL
band	NULL
(	NULL
Fig	NULL
6A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
is	NULL
caused	NULL
by	NULL
the	NULL
STAT5A	NULL
protein	NULL
on	NULL
the	NULL
membrane	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
the	NULL
anti-STAT5B	NULL
immuno-	NULL
IP	NULL
:	NULL
Blot	NULL
:	NULL
Anti-	NULL
5A	NULL
5B	NULL
.	NULL

Anti-phosphotyrosine	NULL
Control	NULL
&	NULL
-	NULL
GMCSF	NULL
Control	NULL
>	NULL
a_®B	NULL
-	NULL
GMCSF	NULL
Control	NULL
GMCSF	NULL
Control	NULL
¥	NULL
«	NULL
-94/92	NULL
94/92kD	NULL
-	NULL
»	NULL
X	NULL
O	NULL
1	NULL
2	NULL
3	NULL
Unk	NULL
epl	NULL
~	NULL
co	NULL
GMCSF	NULL
1209	NULL
Agarose	NULL
GRR	NULL
Anti-STAT5	NULL
-	NULL
LL	NULL
-	NULL
H	NULL
o	NULL
&	NULL
o	NULL
#	NULL
__	NULL
LL	NULL
€	NULL
2C	NULL
o	NULL
&	NULL
0205	NULL
EU	NULL
O	NULL
5	NULL
O	NULL
G	NULL
6	NULL
<	NULL
La	NULL
O	NULL
O	NULL
¥	NULL
<	NULL
-94/92kD	NULL
``	NULL
*-	NULL
B80OkD	NULL
1	NULL
2	NULL
3	NULL
4	NULL
.	NULL

Anti-phosphotyrosine	NULL
94/92kD	NULL
_	NULL
.	NULL

80OkD	NULL
~*	NULL
<	NULL
-94/92kD	NULL
*-	NULL
80kD	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
precipitate	NULL
was	NULL
probed	NULL
with	NULL
anti-STATSA	NULL
,	NULL
there	NULL
was	NULL
a	NULL
substantial	NULL
amount	NULL
of	NULL
STATSA	NULL
brought	NULL
down	NULL
with	NULL
the	NULL
anti-STATSB	NULL
antibody	NULL
(	NULL
Fig	NULL
6A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

There	NULL
was	NULL
a	NULL
doublet	NULL
observed	NULL
in	NULL
the	NULL
anti-STAT5B	NULL
immunoprecipitate	NULL
for	NULL
GM-CSF-treated	NULL
cells	NULL
(	NULL
Fig	NULL
6A	NULL
,	NULL
lane	NULL
8	NULL
v	NULL
7	NULL
)	NULL
.	NULL

The	NULL
upper	NULL
band	NULL
in	NULL
the	NULL
doublet	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
tyrosine-phosphorylated	NULL
form	NULL
of	NULL
STATSB	NULL
(	NULL
see	NULL
Fig	NULL
8	NULL
)	NULL
.	NULL

These	NULL
data	NULL
clearly	NULL
suggested	NULL
that	NULL
heterodimer	NULL
formation	NULL
occurred	NULL
between	NULL
STATSA	NULL
and	NULL
STATS5B	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
.	NULL

The	NULL
data	NULL
were	NULL
also	NULL
consistent	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
STATSA-STATSA	NULL
homodimers	NULL
assembled	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
.	NULL

Therefore	NULL
,	NULL
anti-STATSA	NULL
Anti-STAT5	NULL
Anti-STATS5	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
STATS	NULL
activation	NULL
by	NULL
GM-CSF	NULL
in	NULL
monocyte/	NULL
macrophages	NULL
.	NULL

Monocytes	NULL
were	NULL
cultured	NULL
in	NULL
M-CSF	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
for	NULL
4	NULL
days	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
exposed	NULL
to	NULL
GM-CSF	NULL
(	NULL
50	NULL
ng/mL	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
then	NULL
solubilized	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Fig	NULL
1	NULL
legend	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
(	NULL
anti-STAT5A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
;	NULL
anti-STAT5B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
;	NULL
anti-STAT5	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
were	NULL
separated	NULL
on	NULL
7.5	NULL
%	NULL
SDS-PAGE	NULL
minigels	NULL
and	NULL
transferred	NULL
to	NULL
PVDF	NULL
membranes	NULL
,	NULL
and	NULL
the	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
antibodies	NULL
and	NULL
developed	NULL
using	NULL
ECL	NULL
.	NULL

The	NULL
membrane	NULL
for	NULL
the	NULL
anti-STAT5	NULL
immunoprecipitate	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
was	NULL
reprobed	NULL
with	NULL
the	NULL
immunoprecipitating	NULL
antibody	NULL
and	NULL
developed	NULL
using	NULL
alkaline	NULL
phosphatase	NULL
and	NULL
NBT	NULL
chemistry	NULL
.	NULL

4/92	NULL
pawi	NULL
<	NULL
el	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1210	NULL
ROSEN	NULL
ET	NULL
AL	NULL
Pptn	NULL
:	NULL
Agarose	NULL
GRR	NULL
Blot	NULL
:	NULL
Anti-	NULL
5A	NULL
5B	NULL
Anti-STAT5	NULL
Anti-phosphotyrosine	NULL
6	NULL
t	NULL
50	NULL
s	NULL
d	NULL
u.	NULL
E8EBg	NULL
£8	NULL
C	NULL
6	NULL
2	NULL
0	NULL
(	NULL
ED	NULL
o	NULL
~	NULL
g	NULL
L2	NULL
)	NULL
O	NULL
5	NULL
O	NULL
O	NULL
(	NULL
5	NULL
0	NULL
o	NULL
2C	NULL
--	NULL
Nm	NULL
ls	NULL
``	NULL
L	NULL
_owigr	NULL
_	NULL
_	NULL
,	NULL
94/92	NULL
f	NULL
kD	NULL
kD	NULL
1	NULL
2	NULL
3	NULL
4	NULL
II	NULL
.	NULL

T	NULL
6	NULL
5	NULL
6	NULL
Fig	NULL
4	NULL
.	NULL

STATS	NULL
bound	NULL
to	NULL
the	NULL
GRR	NULL
element	NULL
in	NULL
GM-CSF-treated	NULL
monocyte/macrophages	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Fig	NULL
2	NULL
legend	NULL
.	NULL

After	NULL
exposure	NULL
to	NULL
GM-CSF	NULL
(	NULL
50	NULL
ng/mL	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
37°C	NULL
)	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
solubilized	NULL
in	NULL
whole	NULL
cell	NULL
extract	NULL
buffer	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
GRR-Sepharose	NULL
.	NULL

The	NULL
bound	NULL
proteins	NULL
were	NULL
released	NULL
in	NULL
SDS	NULL
,	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
PVDF	NULL
membranes	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
probed	NULL
for	NULL
STAT5A	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
STAT5B	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
and	NULL
STATS	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
and	NULL
developed	NULL
using	NULL
ECL	NULL
.	NULL

The	NULL
membrane	NULL
for	NULL
the	NULL
anti-STAT5	NULL
immunoprecipitate	NULL
was	NULL
reprobed	NULL
with	NULL
antiphosphotyrosine	NULL
and	NULL
developed	NULL
using	NULL
alkaline	NULL
phosphatase	NULL
and	NULL
NBT	NULL
chemistry	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

immunoprecipitated	NULL
-	NULL
tyrosine	NULL
phosphorylation	NULL
-	NULL
STATSA	NULL
.	NULL

Anti-STATSB	NULL
immunoprecipitated	NULL
tyrosine-phosphorylated	NULL
STATSA	NULL
and	NULL
STATSB	NULL
in	NULL
GM-CSF-treated	NULL
cells	NULL
.	NULL

Because	NULL
much	NULL
more	NULL
STATSA	NULL
than	NULL
STATSB	NULL
bound	NULL
to	NULL
the	NULL
GRR	NULL
in	NULL
the	NULL
Sepharose-GRR	NULL
precipitations	NULL
,	NULL
this	NULL
suggested	NULL
that	NULL
the	NULL
tyrosine-phosphorylated	NULL
band	NULL
observed	NULL
in	NULL
the	NULL
anti-STATSB	NULL
immunoprecipitation	NULL
(	NULL
Figs	NULL
1	NULL
and	NULL
6B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
consisted	NULL
of	NULL
both	NULL
STATSA	NULL
and	NULL
STATSB	NULL
.	NULL

£	NULL
.C	NULL
.C	NULL
€	NULL
£5	NULL
£	NULL
&	NULL
A	NULL
B	NULL
C	NULL
5	NULL
&	NULL
B	NULL
E	NULL
'	NULL
E	NULL
iE	NULL
E	NULL
§	NULL
°	NULL
&	NULL
&	NULL
®	NULL
ass	NULL
_	NULL
WoW	NULL
WOW	NULL
``	NULL
``	NULL
~	NULL
u	NULL
``	NULL
u	NULL
``	NULL
6	NULL
a	NULL
a	NULL
a	NULL
a	NULL
s	NULL
&	NULL
I	NULL
i	NULL
&	NULL
EOOOO	NULL
=	NULL
O	NULL
O	NULL
O	NULL
0	NULL
C-06	NULL
2	NULL
2	NULL
3	NULL
3	NULL
5	NULL
S	NULL
5	NULL
5	NULL
5	NULL
&	NULL
(	NULL
5	NULL
(	NULL
5	NULL
(	NULL
D	NULL
(	NULL
D	NULL
O	NULL
(	NULL
5	NULL
(	NULL
5	NULL
(	NULL
5	NULL
(	NULL
5	NULL
IP	NULL
:	NULL
anti-STAT5A	NULL
Blot	NULL
:	NULL
anti-phosphotyrosine	NULL
Pptn	NULL
:	NULL
GRR	NULL
agarose	NULL
Blot	NULL
:	NULL
anti-STAT5SA	NULL
~	NULL
:	NULL
o	NULL
-	NULL
TTR	NULL
a	NULL
EZ	NULL
lest	NULL
=P	NULL
-	NULL
®	NULL
gg	NULL
-	NULL
-	NULL
&	NULL
=	NULL
&	NULL
&	NULL
*3o	NULL
kp	NULL
a	NULL
Pptn	NULL
:	NULL
GRR	NULL
agarose	NULL
Blot	NULL
:	NULL
anti-STAT5B	NULL
IP	NULL
:	NULL
anti-STAT5B	NULL
Blot	NULL
:	NULL
_anti-phosphotyrosine	NULL
92	NULL
kD	NULL
-	NULL
»	NULL
wus	NULL
Ci	NULL
|	NULL
&	NULL
®	NULL
i	NULL
®	NULL
<	NULL
-92	NULL
kD	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Fig	NULL
5	NULL
.	NULL

Kinetics	NULL
of	NULL
STATS	NULL
activation	NULL
.	NULL

Fresh	NULL
monocytes	NULL
were	NULL
exposed	NULL
to	NULL
GM-CSF	NULL
(	NULL
50	NULL
ng/mL	NULL
)	NULL
for	NULL
various	NULL
times	NULL
at	NULL
37°C	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoprecipitations	NULL
of	NULL
STAT5A	NULL
and	NULL
STATSB	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
processed	NULL
for	NULL
immunoprecipitation	NULL
and	NULL
immunoblotting	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Fig	NULL
1	NULL
legend	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
antibodies	NULL
and	NULL
developed	NULL
using	NULL
ECL	NULL
.	NULL

(	NULL
B	NULL
)	NULL
GRR-agarose	NULL
precipitations	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Fig	NULL
2	NULL
legend	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
probed	NULL
for	NULL
STAT5A	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
STAT5B	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

leos	NULL
Cor	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

GM-CSF	NULL
ACTIVATION	NULL
OF	NULL
STAT5SA	NULL
AND	NULL
STATSB	NULL
IP	NULL
:	NULL
Blot	NULL
:	NULL
Anti-	NULL
5	NULL
94/92kD	NULL
Fig	NULL
6	NULL
.	NULL

Homodimer	NULL
and	NULL
heterodimer	NULL
formation	NULL
of	NULL
STATS	NULL
in	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Monocytes	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Fig	NULL
1	NULL
legend	NULL
.	NULL

Extracts	NULL
were	NULL
made	NULL
and	NULL
the	NULL
STATS	NULL
proteins	NULL
immuno-	NULL
B	NULL
precipitated	NULL
with	NULL
anti-STAT5A	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
or	NULL
anti-STATSB	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
)	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
PVDF	NULL
membranes	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
either	NULL
anti-STATSB	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
)	NULL
or	NULL
anti-STAT5A	NULL
(	NULL
lanes	NULL
3	NULL
through	NULL
6	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
developed	NULL
using	NULL
ECL	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Monocytes	NULL
were	NULL
treated	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
and	NULL
the	NULL
anti-STAT5A	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
and	NULL
anti-STAT5B	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
immunoprecipitates	NULL
were	NULL
immunoblotted	NULL
and	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
.	NULL

The	NULL
monocyte/macrophage	NULL
cells	NULL
were	NULL
also	NULL
examined	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
homodimers	NULL
and	NULL
heterodimers	NULL
of	NULL
STATS	NULL
.	NULL

Extracts	NULL
of	NULL
control	NULL
and	NULL
GM-CSF-treated	NULL
cells	NULL
exposed	NULL
to	NULL
anti-STATS5B	NULL
-	NULL
immunoprecipitated	NULL
STATSA	NULL
from	NULL
GM-CSF-treated	NULL
cells	NULL
only	NULL
(	NULL
Fig	NULL
7A	NULL
,	NULL
lane	NULL
2	NULL
v	NULL
1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
extracts	NULL
immunoprecipitated	NULL
with	NULL
anti-STATSA	NULL
contained	NULL
only	NULL
STATSA	NULL
;	NULL
no	NULL
STATSB	NULL
was	NULL
noted	NULL
(	NULL
Fig	NULL
7A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

That	NULL
the	NULL
STATS	NULL
proteins	NULL
were	NULL
immunoprecipitated	NULL
could	NULL
be	NULL
appreciated	NULL
when	NULL
the	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
anti-STATS	NULL
(	NULL
Fig	NULL
7	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
.	NULL

As	NULL
in	NULL
the	NULL
fresh	NULL
monocytes	NULL
,	NULL
the	NULL
tyrosine-phosphorylated	NULL
band	NULL
observed	NULL
in	NULL
the	NULL
anti-STATSB	NULL
immunoprecipitate	NULL
(	NULL
Fig	NULL
7B	NULL
,	NULL
lane	NULL
4	NULL
v	NULL
2	NULL
)	NULL
was	NULL
probably	NULL
a	NULL
combination	NULL
of	NULL
tyrosine-phosphorylated	NULL
STATSB	NULL
and	NULL
STATSA	NULL
.	NULL

To	NULL
ascertain	NULL
whether	NULL
the	NULL
STATSA	NULL
immunoprecipitated	NULL
with	NULL
STATSB	NULL
contributed	NULL
to	NULL
much	NULL
of	NULL
the	NULL
observed	NULL
tyrosine	NULL
phosphorylated	NULL
protein	NULL
,	NULL
we	NULL
optimized	NULL
standard	NULL
size	NULL
SDS-PAGE	NULL
to	NULL
separate	NULL
the	NULL
STATSA	NULL
and	NULL
STATSB	NULL
proteins	NULL
.	NULL

In	NULL
fresh	NULL
untreated	NULL
monocytes	NULL
,	NULL
there	NULL
was	NULL
a	NULL
clear	NULL
separation	NULL
between	NULL
STATSA	NULL
and	NULL
STATSB	NULL
(	NULL
Fig	NULL
8	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

In	NULL
response	NULL
to	NULL
GM-CSF	NULL
,	NULL
there	NULL
was	NULL
marked	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STATSA	NULL
(	NULL
Fig	NULL
8	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

In	NULL
the	NULL
anti-STATSB	NULL
immunoprecipitate	NULL
,	NULL
a	NULL
triplet	NULL
band	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
8	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

In	NULL
a	NULL
similar	NULL
experi-ment	NULL
,	NULL
when	NULL
the	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
anti-STATSB	NULL
specifically	NULL
,	NULL
this	NULL
triplet	NULL
band	NULL
was	NULL
also	NULL
observed	NULL
with	NULL
the	NULL
uppermost	NULL
band	NULL
corresponding	NULL
to	NULL
the	NULL
predominant	NULL
tyrosine-phosphorylated	NULL
STATS	NULL
band	NULL
(	NULL
D.	NULL
Finbloom	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

The	NULL
middle	NULL
band	NULL
of	NULL
the	NULL
triplet	NULL
probably	NULL
represents	NULL
partially	NULL
phosphorylated	NULL
STATSB	NULL
on	NULL
tyrosine	NULL
and	NULL
serine	NULL
and/or	NULL
threonine	NULL
.	NULL

The	NULL
tyrosine-phosphorylated	NULL
band	NULL
in	NULL
the	NULL
anti-STATSB	NULL
migrated	NULL
as	NULL
a	NULL
doublet	NULL
(	NULL
Fig	NULL
8	NULL
,	NULL
upper	NULL
and	NULL
lower	NULL
panels	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
and	NULL
most	NULL
likely	NULL
contained	NULL
both	NULL
Blot	NULL
:	NULL
1211	NULL
Anti-	NULL
5	NULL
J	NULL
>	NULL
on	NULL
J	NULL
on	NULL
J	NULL
>	NULL
on	NULL
J	NULL
g	NULL
|	NULL
g	NULL
|	NULL
J	NULL
(	NULL
z	NULL
|	NULL
|g	NULL
|	NULL
JO	NULL
Control	NULL
Control	NULL
|	NULL
amcsFr	NULL
B-	NULL
&	NULL
a	NULL
PWL	NULL
Control	NULL
Control	NULL
ro	NULL
Bim	NULL
amcsr	NULL
<	NULL
-94/92kD	NULL
*	NULL
80kD	NULL
mlgl—GMCSF	NULL
_	NULL
[	NULL
de	NULL
]	NULL
~I	NULL
CoO	NULL
Anti-phosphotyrosine	NULL
94/92kD	NULL
-	NULL
__	NULL
«	NULL
a_	NULL
«	NULL
=	NULL
*	NULL
Soll	NULL
1	NULL
2	NULL
3	NULL
4	NULL
STATSA	NULL
and	NULL
STATSB	NULL
.	NULL

A	NULL
similar	NULL
scenario	NULL
occurred	NULL
with	NULL
M-CSF-driven	NULL
macrophages	NULL
(	NULL
Fig	NULL
8	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Activation	NULL
of	NULL
STAT	NULL
proteins	NULL
is	NULL
now	NULL
regarded	NULL
as	NULL
a	NULL
unifying	NULL
event	NULL
for	NULL
cytokine	NULL
and	NULL
growth	NULL
factor-induced	NULL
signal	NULL
transduction	NULL
.	NULL

Activation	NULL
of	NULL
STATS	NULL
occurs	NULL
in	NULL
response	NULL
to	NULL
several	NULL
seemingly	NULL
unrelated	NULL
cytokines	NULL
,	NULL
including	NULL
GM-CSF	NULL
,	NULL
IL-2	NULL
,	NULL
thrombopoietin	NULL
,	NULL
erythropoietin	NULL
,	NULL
IL-3	NULL
,	NULL
IL-5	NULL
,	NULL
interferon-	NULL
«	NULL
(	NULL
IFN-a	NULL
)	NULL
,	NULL
prolactin	NULL
,	NULL
and	NULL
growth	NULL
hormone	NULL
.	NULL

Unlike	NULL
the	NULL
other	NULL
known	NULL
STAT	NULL
proteins	NULL
,	NULL
STATS	NULL
consists	NULL
of	NULL
two	NULL
highly	NULL
homologous	NULL
proteins	NULL
,	NULL
STATSA	NULL
and	NULL
STATSB	NULL
,	NULL
whose	NULL
differential	NULL
activation	NULL
by	NULL
GM-CSF	NULL
is	NULL
the	NULL
subject	NULL
of	NULL
this	NULL
report	NULL
.	NULL

In	NULL
monocytes	NULL
,	NULL
we	NULL
show	NULL
that	NULL
GM-CSF	NULL
appears	NULL
to	NULL
induce	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
STATSA	NULL
and	NULL
STATSB	NULL
when	NULL
each	NULL
protein	NULL
is	NULL
immunoprecipitated	NULL
with	NULL
its	NULL
specific	NULL
antibody	NULL
.	NULL

However	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
tyrosine-phosphorylated	NULL
band	NULL
on	NULL
SDS-PAGE	NULL
is	NULL
essentially	NULL
identical	NULL
for	NULL
both	NULL
the	NULL
anti-STAT5SA	NULL
and	NULL
anti-STATS5B	NULL
immunoprecipitate	NULL
suggests	NULL
the	NULL
possibility	NULL
that	NULL
one	NULL
STATS	NULL
may	NULL
be	NULL
preferentially	NULL
activated	NULL
over	NULL
the	NULL
other	NULL
and	NULL
immunoprecipitated	NULL
as	NULL
a	NULL
heterodimeric	NULL
complex	NULL
.	NULL

Homodimers	NULL
and	NULL
heterodimers	NULL
of	NULL
STAT	NULL
proteins	NULL
have	NULL
been	NULL
described	NULL
for	NULL
STAT	NULL
!	NULL

and	NULL
STAT3	NULL
in	NULL
response	NULL
to	NULL
IL-10	NULL
.	NULL

'®	NULL
In	NULL
our	NULL
studies	NULL
,	NULL
when	NULL
the	NULL
anti-STATS5B	NULL
immunoprecipitates	NULL
are	NULL
probed	NULL
with	NULL
anti-STATSA	NULL
,	NULL
STATSA	NULL
is	NULL
present	NULL
,	NULL
indicating	NULL
that	NULL
STATSA-STATSB	NULL
heterodimer	NULL
formation	NULL
occurs	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
in	NULL
the	NULL
anti-STATS5A	NULL
immunoprecipitations	NULL
only	NULL
STATSA	NULL
is	NULL
observed	NULL
suggests	NULL
that	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
STATSA-STATSA	NULL
homodimers	NULL
assemble	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
.	NULL

Because	NULL
there	NULL
is	NULL
more	NULL
STATSA	NULL
than	NULL
STATSB	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
immobilized	NULL
GRR	NULL
from	NULL
GM-CSF-treated	NULL
extracts	NULL
,	NULL
activation	NULL
of	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1212	NULL
A	NULL
_	NULL
IP	NULL
:	NULL
Anti-	NULL
STATSB	NULL
STATSA	NULL
Blot	NULL
:	NULL
Anti-	NULL
_	NULL
5	NULL
J	NULL
>	NULL
\	NULL
on	NULL
on	NULL
uel	NULL
n	NULL
=z	NULL
bbe	NULL
<	NULL
e	NULL
<	NULL
e	NULL
He	NULL
=p	NULL
s	NULL
6	NULL
ESS	NULL
f	NULL
s	NULL
=	NULL
5	NULL
5	NULL
=	NULL
5	NULL
O	NULL
G	NULL
O	NULL
O	NULL
G	NULL
O	NULL
94/92	NULL
|	NULL
__	NULL
__	NULL
“	NULL
L	NULL
;	NULL
‘	NULL
_	NULL
kD	NULL
wt	NULL
L	NULL
L	NULL
4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
IP	NULL
:	NULL
_	NULL
Anti-5A	NULL
5B	NULL
Blot	NULL
:	NULL
Anti-phosphotyrosine	NULL
94/92	NULL
o	NULL
~*	NULL
8	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Fig	NULL
7	NULL
.	NULL

-	NULL
Homodimer	NULL
and	NULL
heterodimer	NULL
formation	NULL
of	NULL
STATS	NULL
in	NULL
monocyte/macrophages	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Fig	NULL
2	NULL
legend	NULL
.	NULL

Extracts	NULL
were	NULL
made	NULL
and	NULL
the	NULL
STATS	NULL
proteins	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-STAT5B	NULL
(	NULL
lanes	NULL
1	NULL
through	NULL
3	NULL
)	NULL
or	NULL
anti-STAT5A	NULL
(	NULL
lanes	NULL
4	NULL
through	NULL
6	NULL
)	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
PVDF	NULL
membranes	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
either	NULL
anti-STAT5A	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
anti-STAT5B	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
or	NULL
anti-STAT5	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
developed	NULL
using	NULL
ECL	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cells	NULL
were	NULL
treated	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
and	NULL
the	NULL
anti-STAT5A	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
and	NULL
anti-STAT5B	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
immunoprecipitates	NULL
were	NULL
immunoblotted	NULL
and	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
.	NULL

STATSA	NULL
occurs	NULL
to	NULL
a	NULL
greater	NULL
extent	NULL
in	NULL
monocytes	NULL
exposed	NULL
to	NULL
GM-CSF	NULL
.	NULL

Standard	NULL
size	NULL
SDS-PAGE	NULL
shows	NULL
that	NULL
the	NULL
tyrosine-phosphorylated	NULL
STATSB	NULL
migrates	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
STATSA	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
band	NULL
observed	NULL
by	NULL
phosphotyrosine	NULL
immunobloting	NULL
contains	NULL
both	NULL
STATS	NULL
isoforms	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
STATS	NULL
dimer	NULL
formation	NULL
that	NULL
is	NULL
at	NULL
least	NULL
STATSA	NULL
homodimers	NULL
and	NULL
STATSA-STATSB	NULL
hetero-dimers	NULL
.	NULL

However	NULL
,	NULL
the	NULL
data	NULL
do	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
of	NULL
STATSB	NULL
homodimers	NULL
also	NULL
.	NULL

Lower	NULL
molecular	NULL
weight	NULL
forms	NULL
of	NULL
STAT	NULL
proteins	NULL
have	NULL
occasionally	NULL
been	NULL
described	NULL
since	NULL
the	NULL
initial	NULL
observation	NULL
of	NULL
STAT1/3	NULL
as	NULL
an	NULL
alternately	NULL
spiced	NULL
variant	NULL
of	NULL
STAT1a	NULL
.	NULL
``	NULL

Although	NULL
we	NULL
have	NULL
previously	NULL
identified	NULL
an	NULL
80-kD	NULL
tyrosine	NULL
phosphoprotein	NULL
that	NULL
binds	NULL
the	NULL
GRR	NULL
element	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
,	NULL
``	NULL
it	NULL
is	NULL
only	NULL
recently	NULL
that	NULL
other	NULL
investigators	NULL
have	NULL
noted	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
lower	NULL
molecular	NULL
weight	NULL
STATS	NULL
of	NULL
77	NULL
and	NULL
79	NULL
kD	NULL
isolated	NULL
from	NULL
IL-3-treated	NULL
myeloid	NULL
cell	NULL
line	NULL
using	NULL
a	NULL
GRR-like	NULL
element	NULL
.	NULL
``	NULL

Interestingly	NULL
,	NULL
no	NULL
full-length	NULL
94/	NULL
92-kD	NULL
STATSA	NULL
protein	NULL
was	NULL
isolated	NULL
in	NULL
this	NULL
manner	NULL
.	NULL

This	NULL
ROSEN	NULL
ET	NULL
AL	NULL
suggests	NULL
,	NULL
along	NULL
with	NULL
our	NULL
findings	NULL
,	NULL
that	NULL
the	NULL
tyrosine-phosphorylated	NULL
80-kD	NULL
protein	NULL
is	NULL
only	NULL
observable	NULL
on	NULL
GRR-Sepharose	NULL
and	NULL
that	NULL
these	NULL
lower	NULL
molecular	NULL
weight	NULL
forms	NULL
may	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
gene	NULL
regulation	NULL
.	NULL

When	NULL
cells	NULL
treated	NULL
with	NULL
GM-CSF	NULL
have	NULL
been	NULL
solubilized	NULL
with	NULL
the	NULL
same	NULL
buffer	NULL
used	NULL
for	NULL
the	NULL
GRR-agarose	NULL
precipitations	NULL
,	NULL
anti-STAT5A	NULL
antibodies	NULL
will	NULL
detect	NULL
the	NULL
tyrosine-phosphorylated	NULL
80-kD	NULL
STATSA	NULL
(	NULL
D.	NULL
Finbloom	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
either	NULL
the	NULL
tyrosine-phosphorylated	NULL
80-kD	NULL
STATSA	NULL
rapidly	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
is	NULL
therefore	NULL
poorly	NULL
extracted	NULL
from	NULL
the	NULL
nucleus	NULL
by	NULL
the	NULL
immunoprecipitation	NULL
buffer	NULL
or	NULL
that	NULL
the	NULL
80-kD	NULL
STATSA	NULL
is	NULL
generated	NULL
from	NULL
94-kD	NULL
STATSA	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

The	NULL
data	NULL
do	NULL
not	NULL
allow	NULL
for	NULL
a	NULL
distinction	NULL
to	NULL
be	NULL
make	NULL
at	NULL
this	NULL
time	NULL
.	NULL

Not	NULL
all	NULL
cells	NULL
(	NULL
eg	NULL
,	NULL
T-cell	NULL
blasts	NULL
)	NULL
express	NULL
the	NULL
lower	NULL
molecular	NULL
weight	NULL
forms	NULL
of	NULL
STATS	NULL
and	NULL
the	NULL
mechanism	NULL
generating	NULL
this	NULL
protein	NULL
may	NULL
be	NULL
variable	NULL
.	NULL

In	NULL
another	NULL
study	NULL
examining	NULL
activation	NULL
of	NULL
STATS	NULL
homologues	NULL
by	NULL
IL-3	NULL
in	NULL
murine	NULL
OTT-1	NULL
cells	NULL
,	NULL
a	NULL
hematopoietic	NULL
cell	NULL
line	NULL
,	NULL
both	NULL
STATSA	NULL
and	NULL
5B	NULL
are	NULL
equally	NULL
activated	NULL
,	NULL
but	NULL
no	NULL
lower	NULL
molecular	NULL
weight	NULL
form	NULL
is	NULL
identified	NULL
.	NULL
``	NULL

Similarly	NULL
,	NULL
in	NULL
studies	NULL
addressing	NULL
the	NULL
activation	NULL
of	NULL
STATS	NULL
by	NULL
IL-2	NULL
,	NULL
only	NULL
full-length	NULL
STATS	NULL
is	NULL
observed	NULL
.	NULL

In	NULL
none	NULL
of	NULL
the	NULL
IL-2	NULL
studies	NULL
is	NULL
there	NULL
made	NULL
a	NULL
distinction	NULL
between	NULL
the	NULL
STAT	NULL
homologues	NULL
;	NULL
there	NULL
is	NULL
also	NULL
not	NULL
any	NULL
mention	NULL
of	NULL
a	NULL
lower	NULL
molecular	NULL
weight	NULL
species	NULL
.	NULL
``	NULL

''	NULL
However	NULL
,	NULL
in	NULL
the	NULL
one	NULL
study	NULL
that	NULL
actually	NULL
purifies	NULL
the	NULL
IL-2-induced	NULL
STATS	NULL
on	NULL
a	NULL
GRR-like	NULL
element	NULL
,	NULL
on	NULL
probing	NULL
tissues	NULL
for	NULL
STATS	NULL
mRNA	NULL
,	NULL
there	NULL
are	NULL
two	NULL
predominant	NULL
mRNAs	NULL
at	NULL
6	NULL
and	NULL
4	NULL
kb	NULL
that	NULL
correspond	NULL
to	NULL
STATSB	NULL
and	NULL
STATSA	NULL
,	NULL
respectively	NULL
.	NULL
``	NULL

Moreover	NULL
,	NULL
in	NULL
some	NULL
tissues	NULL
,	NULL
notably	NULL
placenta	NULL
,	NULL
testis	NULL
,	NULL
and	NULL
mus-cle	NULL
,	NULL
there	NULL
is	NULL
a	NULL
smaller	NULL
(	NULL
3	NULL
kb	NULL
)	NULL
mRNA	NULL
that	NULL
was	NULL
not	NULL
further	NULL
characterized	NULL
.	NULL
``	NULL

In	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
,	NULL
we	NULL
observe	NULL
that	NULL
the	NULL
80kD	NULL
protein	NULL
is	NULL
antigenically	NULL
related	NULL
to	NULL
STATSA	NULL
but	NULL
not	NULL
to	NULL
STATSB	NULL
.	NULL

Its	NULL
potential	NULL
role	NULL
in	NULL
transcription	NULL
is	NULL
suggested	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
80-kD	NULL
STATSA	NULL
along	NULL
with	NULL
the	NULL
94-kD	NULL
STATSA	NULL
binds	NULL
to	NULL
the	NULL
GRR	NULL
element	NULL
,	NULL
is	NULL
tyrosine-phosphory-lated	NULL
,	NULL
and	NULL
seems	NULL
to	NULL
be	NULL
exclusively	NULL
located	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
only	NULL
one	NULL
of	NULL
the	NULL
STATS	NULL
homologues	NULL
has	NULL
a	NULL
shortened	NULL
form	NULL
and	NULL
that	NULL
this	NULL
may	NULL
be	NULL
tissue	NULL
specific	NULL
is	NULL
not	NULL
inconsistent	NULL
because	NULL
lower	NULL
molecular	NULL
weight	NULL
STATS	NULL
isolated	NULL
from	NULL
liver	NULL
was	NULL
only	NULL
observed	NULL
for	NULL
STATSB	NULL
.	NULL

'°	NULL
Because	NULL
the	NULL
anti-STATSA	NULL
was	NULL
prepared	NULL
with	NULL
a	NULL
peptide	NULL
consisting	NULL
of	NULL
the	NULL
COOH	NULL
terminal	NULL
amino	NULL
acids	NULL
of	NULL
STATSA	NULL
,	NULL
a	NULL
simple	NULL
truncation	NULL
can	NULL
not	NULL
explain	NULL
the	NULL
presence	NULL
of	NULL
this	NULL
shortened	NULL
form	NULL
.	NULL

Perhaps	NULL
an	NULL
alternative	NULL
splicing	NULL
event	NULL
occurs	NULL
,	NULL
as	NULL
is	NULL
observed	NULL
with	NULL
STAT13	NULL
.	NULL

Differentiation	NULL
of	NULL
monocytes	NULL
into	NULL
macrophages	NULL
is	NULL
known	NULL
to	NULL
have	NULL
effects	NULL
on	NULL
STAT1	NULL
activation	NULL
by	NULL
cytokines	NULL
such	NULL
as	NULL
IFN-y	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
different	NULL
GAS	NULL
binding	NULL
factors	NULL
are	NULL
observed	NULL
when	NULL
comparing	NULL
immature	NULL
and	NULL
mature	NULL
myeloid	NULL
cells	NULL
.	NULL
``	NULL

When	NULL
macrophages	NULL
are	NULL
generated	NULL
by	NULL
culture	NULL
in	NULL
M-CSF	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
80-kD	NULL
STATSA	NULL
is	NULL
greatly	NULL
reduced	NULL
or	NULL
lost	NULL
altogether	NULL
.	NULL

With	NULL
the	NULL
GRR-Sepharose	NULL
precipitations	NULL
,	NULL
a	NULL
very	NULL
weak	NULL
80-kD	NULL
band	NULL
can	NULL
occasionally	NULL
be	NULL
noted	NULL
,	NULL
but	NULL
in	NULL
other	NULL
experiments	NULL
no	NULL
evidence	NULL
of	NULL
the	NULL
80-kD	NULL
STATSA	NULL
is	NULL
seen	NULL
(	NULL
D.	NULL
Finbloom	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
,	NULL
along	NULL
with	NULL
those	NULL
from	NULL
the	NULL
studies	NULL
of	NULL
others	NULL
,	NULL
suggest	NULL
that	NULL
the	NULL
degree	NULL
of	NULL
differentiation	NULL
of	NULL
cells	NULL
can	NULL
affect	NULL
the	NULL
STAT	NULL
proteins	NULL
expressed	NULL
and	NULL
activated	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
appreciated	NULL
that	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
tyro	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

GM-CSF	NULL
ACTIVATION	NULL
OF	NULL
STAT5A	NULL
AND	NULL
STAT5B	NULL
Anti-	NULL
STATSA	NULL
STATSB	NULL
STATSA	NULL
Anti-STAT5	NULL
__	NULL
LL	NULL
-	NULL
__	NULL
L	NULL
2	NULL
g	NULL
5	NULL
&	NULL
5	NULL
S	NULL
5	NULL
5	NULL
O	NULL
5	NULL
O	NULL
5	NULL
STAT	NULL
5A	NULL
-	NULL
>	NULL
Wie	NULL
cng	NULL
ik	NULL
STATSB	NULL
-	NULL
»	NULL
STATSALL4L	NULL
._	NULL
.	NULL

STAT5B	NULL
~*	NULL
10	NULL
2	NULL
3	NULL
4	NULL
1213	NULL
STAT5SB	NULL
Anti-phosphotyrosine	NULL
az	NULL
Lh	NULL
_	NULL
LL	NULL
2	NULL
8	NULL
o	NULL
8	NULL
5	NULL
S	NULL
5	NULL
S	NULL
O	NULL
D	NULL
O	NULL
D5	NULL
-I	NULL
lim	NULL
<	NULL
-	NULL
STATSA/E	NULL
@	NULL
R	NULL
<	NULL
-	NULL
STATSNB	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Fig	NULL
8	NULL
.	NULL

-	NULL
GM-CSF	NULL
preferentially	NULL
activates	NULL
STAT5A	NULL
.	NULL

Monocytes	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
Upper	NULL
panel	NULL
)	NULL
Freshly	NULL
isolated	NULL
monocytes	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
GM-CSF	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Fig	NULL
1	NULL
legend	NULL
and	NULL
processed	NULL
for	NULL
immunoprecipitation	NULL
with	NULL
anti-STAT5A	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
or	NULL
anti-STATSB	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
)	NULL
and	NULL
immunoblot	NULL
analysis	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
analyzed	NULL
on	NULL
standard	NULL
15-cm	NULL
8	NULL
%	NULL
gels	NULL
.	NULL

Lanes	NULL
1	NULL
through	NULL
4	NULL
represent	NULL
the	NULL
membrane	NULL
probed	NULL
with	NULL
anti-STATS5	NULL
and	NULL
lanes	NULL
5	NULL
through	NULL
8	NULL
represent	NULL
the	NULL
membrane	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
.	NULL

(	NULL
Lower	NULL
panel	NULL
)	NULL
M-CSF-driven	NULL
monocyte/macrophages	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
GM-CSF	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Fig	NULL
3	NULL
legend	NULL
and	NULL
processed	NULL
for	NULL
immunoprecipitation	NULL
and	NULL
immunoblot	NULL
analysis	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Lanes	NULL
1	NULL
through	NULL
4	NULL
represent	NULL
the	NULL
membrane	NULL
probed	NULL
with	NULL
anti-STATS	NULL
and	NULL
lanes	NULL
5	NULL
through	NULL
8	NULL
represent	NULL
the	NULL
membrane	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
.	NULL

sine	NULL
phosphorylation	NULL
,	NULL
transcriptional	NULL
activation	NULL
may	NULL
require	NULL
the	NULL
phosphorylation	NULL
of	NULL
a	NULL
serine	NULL
within	NULL
a	NULL
MAP	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
site	NULL
(	NULL
XPXSP	NULL
)	NULL
close	NULL
to	NULL
the	NULL
COOH	NULL
terminus	NULL
of	NULL
some	NULL
STAT	NULL
proteins	NULL
.	NULL
``	NULL

Although	NULL
some	NULL
of	NULL
the	NULL
STATs	NULL
appear	NULL
to	NULL
have	NULL
a	NULL
MAPK	NULL
consensus	NULL
sequence	NULL
at	NULL
the	NULL
COOH	NULL
terminal	NULL
region	NULL
that	NULL
is	NULL
important	NULL
for	NULL
transactivation	NULL
,	NULL
``	NULL
this	NULL
is	NULL
not	NULL
the	NULL
case	NULL
for	NULL
STATSA	NULL
or	NULL
STATSB	NULL
.	NULL
``	NULL

This	NULL
site	NULL
in	NULL
the	NULL
human	NULL
STATSA	NULL
is	NULL
DSRLSP	NULL
.	NULL
``	NULL

This	NULL
sequence	NULL
retains	NULL
the	NULL
serine	NULL
on	NULL
the	NULL
COOH	NULL
half	NULL
,	NULL
but	NULL
does	NULL
not	NULL
have	NULL
the	NULL
important	NULL
proline	NULL
on	NULL
the	NULL
NH2	NULL
half	NULL
of	NULL
the	NULL
region	NULL
.	NULL

STATSB	NULL
lacks	NULL
all	NULL
aspects	NULL
of	NULL
a	NULL
MAPK	NULL
consensus	NULL
site	NULL
.	NULL
``	NULL

However	NULL
,	NULL
it	NULL
is	NULL
of	NULL
interest	NULL
that	NULL
ligand-induced	NULL
transcription	NULL
of	NULL
a	NULL
STATSA	NULL
driven	NULL
luciferase	NULL
construct	NULL
is	NULL
about	NULL
sixfold	NULL
to	NULL
sevenfold	NULL
greater	NULL
than	NULL
the	NULL
comparable	NULL
STATSB-driven	NULL
construct	NULL
.	NULL
``	NULL

This	NULL
may	NULL
,	NULL
in	NULL
part	NULL
,	NULL
be	NULL
one	NULL
reason	NULL
for	NULL
the	NULL
preferential	NULL
activation	NULL
of	NULL
STATSA	NULL
over	NULL
STATS5B	NULL
and	NULL
may	NULL
point	NULL
to	NULL
the	NULL
COOH	NULL
terminal	NULL
region	NULL
of	NULL
STATSA	NULL
as	NULL
important	NULL
for	NULL
ligand-induced	NULL
transactivation	NULL
by	NULL
an	NULL
as	NULL
yet	NULL
undefined	NULL
mechanism	NULL
.	NULL

The	NULL
cellular	NULL
genes	NULL
that	NULL
are	NULL
dependent	NULL
on	NULL
GM-CSF-acti-vated	NULL
STAT	NULL
proteins	NULL
are	NULL
ill-defined	NULL
.	NULL

Genes	NULL
encoding	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
expression	NULL
are	NULL
enhanced	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
,	NULL
but	NULL
the	NULL
role	NULL
for	NULL
STAT	NULL
proteins	NULL
in	NULL
their	NULL
enhancement	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Other	NULL
genes	NULL
such	NULL
as	NULL
intracellular	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
are	NULL
induced	NULL
by	NULL
GM-CSF	NULL
,	NULL
``	NULL
°	NULL
but	NULL
the	NULL
role	NULL
of	NULL
STAT	NULL
protein	NULL
involvement	NULL
can	NULL
only	NULL
be	NULL
inferred	NULL
from	NULL
studies	NULL
using	NULL
IFN-y	NULL
activation	NULL
of	NULL
ICAM-1	NULL
.	NULL

Reciprocal	NULL
relationships	NULL
between	NULL
inducers	NULL
of	NULL
genes	NULL
and	NULL
the	NULL
gene	NULL
products	NULL
are	NULL
beginning	NULL
to	NULL
be	NULL
appreci-ated	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
binding	NULL
of	NULL
CD4	NULL
positive	NULL
T	NULL
cells	NULL
to	NULL
ICAM-1	NULL
will	NULL
induce	NULL
the	NULL
secretion	NULL
of	NULL
GM-CSF	NULL
,	NULL
``	NULL
which	NULL
then	NULL
goes	NULL
on	NULL
to	NULL
enhance	NULL
ICAM-1	NULL
expression	NULL
in	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
IFN-y	NULL
will	NULL
enhance	NULL
GM-CSF	NULL
receptor	NULL
expression	NULL
,	NULL
``	NULL
which	NULL
may	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
lead	NULL
to	NULL
increased	NULL
signaling	NULL
by	NULL
GM-CSF	NULL
and	NULL
modulation	NULL
of	NULL
IFN-y	NULL
responsiveness	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
a	NULL
thorough	NULL
under	NULL
standing	NULL
of	NULL
the	NULL
activation	NULL
of	NULL
STATS	NULL
homologues	NULL
and	NULL
their	NULL
variants	NULL
by	NULL
GM-CSF	NULL
will	NULL
allow	NULL
for	NULL
a	NULL
better	NULL
understanding	NULL
of	NULL
its	NULL
various	NULL
effects	NULL
in	NULL
a	NULL
prime	NULL
cellular	NULL
target	NULL
such	NULL
as	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

REFERENCES	NULL
[	NULL
.	NULL

Larner	NULL
AC	NULL
,	NULL
David	NULL
M	NULL
,	NULL
Feldman	NULL
GM	NULL
,	NULL
Igarashi	NULL
K	NULL
,	NULL
Hackett	NULL
RH	NULL
,	NULL
Webb	NULL
DAS	NULL
,	NULL
Sweitzer	NULL
SM	NULL
,	NULL
Petricoin	NULL
EF	NULL
III	NULL
,	NULL
Finbloom	NULL
DS	NULL
:	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
by	NULL
multiple	NULL
cytokines	NULL
.	NULL

Science	NULL
261:1730	NULL
,	NULL
1993	NULL
2	NULL
.	NULL

Quelle	NULL
FW	NULL
,	NULL
Sato	NULL
N	NULL
,	NULL
Witthun	NULL
BA	NULL
,	NULL
Inhorn	NULL
RC	NULL
,	NULL
Eder	NULL
M	NULL
,	NULL
Miyajima	NULL
A	NULL
,	NULL
Griffin	NULL
JD	NULL
,	NULL
Ihle	NULL
JN	NULL
:	NULL
JAK2	NULL
Associates	NULL
with	NULL
the	NULL
3.	NULL
chain	NULL
of	NULL
the	NULL
receptor	NULL
for	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
its	NULL
activation	NULL
requires	NULL
the	NULL
membrane-proximal	NULL
region	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:4335	NULL
,	NULL
1994	NULL
3	NULL
.	NULL

Larner	NULL
AC	NULL
,	NULL
Finbloom	NULL
DS	NULL
:	NULL
Protein	NULL
tyrosine	NULL
phosphorylation	NULL
as	NULL
a	NULL
mechanism	NULL
which	NULL
regulates	NULL
cytokine	NULL
activation	NULL
of	NULL
early	NULL
respone	NULL
genes	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1266:278	NULL
,	NULL
1995	NULL
4	NULL
.	NULL

Finbloom	NULL
DS	NULL
,	NULL
Larner	NULL
AC	NULL
:	NULL
Induction	NULL
of	NULL
early	NULL
response	NULL
genes	NULL
by	NULL
interferons	NULL
,	NULL
interleukins	NULL
,	NULL
and	NULL
growth	NULL
factors	NULL
by	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
latent	NULL
transcription	NULL
factors	NULL
:	NULL
Implications	NULL
for	NULL
inflammatory	NULL
diseases	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
38:877	NULL
,	NULL
1995	NULL
5	NULL
.	NULL

Thle	NULL
JN	NULL
,	NULL
Witthuhn	NULL
BA	NULL
,	NULL
Quelle	NULL
FW	NULL
,	NULL
Yamamoto	NULL
K	NULL
,	NULL
Silvennoinen	NULL
O	NULL
:	NULL
Signaling	NULL
through	NULL
the	NULL
hematopoietic	NULL
cytokine	NULL
receptors	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
13:369	NULL
,	NULL
1995	NULL
6	NULL
.	NULL

Wakao	NULL
H	NULL
,	NULL
Gouilleux	NULL
F	NULL
,	NULL
Groner	NULL
B	NULL
:	NULL
Mammary	NULL
gland	NULL
factor	NULL
(	NULL
MGF	NULL
)	NULL
is	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
cytokine	NULL
regulated	NULL
transcription	NULL
factor	NULL
gene	NULL
family	NULL
and	NULL
confers	NULL
prolactin	NULL
response	NULL
.	NULL

EMBO	NULL
J	NULL
13:2182	NULL
,	NULL
1994	NULL
7	NULL
.	NULL

Mui	NULL
AL	NULL
,	NULL
Wakao	NULL
H	NULL
,	NULL
O'Farrell	NULL
A-M	NULL
,	NULL
Harada	NULL
N	NULL
,	NULL
Miyajima	NULL
A	NULL
:	NULL
Interleukin-3	NULL
,	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
and	NULL
interleukin-5	NULL
transduce	NULL
signals	NULL
through	NULL
two	NULL
STATS	NULL
homologs	NULL
.	NULL

EMBO	NULL
J	NULL
14:1166	NULL
,	NULL
1995	NULL
8	NULL
.	NULL

Gouilleux	NULL
G	NULL
,	NULL
Pallard	NULL
C	NULL
,	NULL
Dusanter-Fourt	NULL
I	NULL
,	NULL
Wakao	NULL
H	NULL
,	NULL
Haldosen	NULL
L	NULL
,	NULL
Norstedt	NULL
G	NULL
,	NULL
Levy	NULL
D	NULL
,	NULL
Groner	NULL
B	NULL
:	NULL
Prolactin	NULL
,	NULL
growth	NULL
hormone	NULL
,	NULL
erythropoietin	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
induce	NULL
MGF-STATS	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

EMBO	NULL
J	NULL
14:2005	NULL
,	NULL
1995	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1214	NULL
9	NULL
.	NULL

Pallard	NULL
C	NULL
,	NULL
Gouilleux	NULL
F	NULL
,	NULL
Benit	NULL
L	NULL
,	NULL
Coault	NULL
L	NULL
,	NULL
Souyri	NULL
M	NULL
,	NULL
Levy	NULL
D	NULL
,	NULL
Groner	NULL
B	NULL
,	NULL
Gisselbrecht	NULL
S	NULL
,	NULL
Dusanter-Fourt	NULL
I	NULL
:	NULL
Thrombopoietin	NULL
activates	NULL
a	NULL
STATS5-like	NULL
factor	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
14:2847	NULL
,	NULL
1995	NULL
10	NULL
.	NULL

Hou	NULL
J	NULL
,	NULL
Schindler	NULL
U	NULL
,	NULL
Henzel	NULL
WJ	NULL
,	NULL
Wong	NULL
SC	NULL
,	NULL
McKnight	NULL
SL	NULL
:	NULL
Identification	NULL
and	NULL
purification	NULL
of	NULL
human	NULL
Stat	NULL
proteins	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
.	NULL

Immunity	NULL
2:321	NULL
,	NULL
1995	NULL
11	NULL
.	NULL

Lin	NULL
J-X	NULL
,	NULL
Migone	NULL
T-S	NULL
,	NULL
Tsang	NULL
M	NULL
,	NULL
Freidmann	NULL
M	NULL
,	NULL
Weatherbee	NULL
JA	NULL
,	NULL
Zhou	NULL
L	NULL
,	NULL
Yamauchi	NULL
A	NULL
,	NULL
Bloom	NULL
ET	NULL
,	NULL
Mietz	NULL
J	NULL
,	NULL
John	NULL
S	NULL
,	NULL
Leonard	NULL
WJ	NULL
:	NULL
The	NULL
role	NULL
of	NULL
shared	NULL
receptor	NULL
motifs	NULL
and	NULL
common	NULL
Stat	NULL
proteins	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
cytokine	NULL
pleiotropy	NULL
and	NULL
redundancy	NULL
by	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
IL-13	NULL
,	NULL
and	NULL
IL-15	NULL
.	NULL

Immunity	NULL
2:331	NULL
,	NULL
1995	NULL
12	NULL
.	NULL

Azam	NULL
M	NULL
,	NULL
Erdjument-Bromage	NULL
H	NULL
,	NULL
Kreider	NULL
BL	NULL
,	NULL
Xia	NULL
M	NULL
,	NULL
Quelle	NULL
F	NULL
,	NULL
Basu	NULL
R	NULL
,	NULL
Saris	NULL
C	NULL
,	NULL
Tempst	NULL
P	NULL
,	NULL
Thle	NULL
JN	NULL
,	NULL
Schindler	NULL
C	NULL
:	NULL
Interleukin-3	NULL
signals	NULL
through	NULL
multiple	NULL
isoforms	NULL
of	NULL
STATS	NULL
.	NULL

EMBO	NULL
J	NULL
14:1402	NULL
,	NULL
1995	NULL
13	NULL
.	NULL

Ivashkiv	NULL
LB	NULL
:	NULL
Cytokines	NULL
and	NULL
STATs	NULL
:	NULL
How	NULL
can	NULL
signals	NULL
achieve	NULL
specificity	NULL
.	NULL

Immunity	NULL
3:1	NULL
,	NULL
1995	NULL
14	NULL
.	NULL

Thile	NULL
JN	NULL
:	NULL
STATs	NULL
:	NULL
Signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
tran-scription	NULL
.	NULL

Cell	NULL
84:331	NULL
,	NULL
1996	NULL
15	NULL
.	NULL

Liu	NULL
X	NULL
,	NULL
Robinson	NULL
GW	NULL
,	NULL
Gouilleux	NULL
F	NULL
,	NULL
Groner	NULL
B	NULL
,	NULL
Hennighausen	NULL
L	NULL
:	NULL
Cloning	NULL
and	NULL
expression	NULL
of	NULL
STATS	NULL
and	NULL
an	NULL
additional	NULL
homologue	NULL
(	NULL
STATS5b	NULL
)	NULL
involved	NULL
in	NULL
prolactin	NULL
signal	NULL
transduction	NULL
in	NULL
mouse	NULL
mammary	NULL
tissues	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:8831	NULL
,	NULL
1995	NULL
16	NULL
.	NULL

Ripperger	NULL
JA	NULL
,	NULL
Fritz	NULL
S	NULL
,	NULL
Richter	NULL
K	NULL
,	NULL
Hocke	NULL
GM	NULL
,	NULL
Lottspeich	NULL
F	NULL
,	NULL
Fey	NULL
FH	NULL
:	NULL
Transcription	NULL
factors	NULL
STAT3	NULL
and	NULL
STAT5b	NULL
are	NULL
present	NULL
in	NULL
rat	NULL
liver	NULL
nuclei	NULL
late	NULL
in	NULL
an	NULL
acute	NULL
phase	NULL
response	NULL
and	NULL
bind	NULL
interleukin-6	NULL
response	NULL
elements	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:29998	NULL
,	NULL
1995	NULL
17	NULL
.	NULL

Munn	NULL
DH	NULL
,	NULL
Armstrong	NULL
E	NULL
:	NULL
Cytokine	NULL
regulation	NULL
of	NULL
human	NULL
monocyte	NULL
differentiation	NULL
in	NULL
vitro	NULL
:	NULL
The	NULL
tumor-cytotoxic	NULL
phenotype	NULL
induced	NULL
by	NULL
macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
is	NULL
developmentally	NULL
regulated	NULL
by	NULL
gamma	NULL
interferon	NULL
.	NULL

Cancer	NULL
Res	NULL
53:2603	NULL
,	NULL
1993	NULL
18	NULL
.	NULL

Finbloom	NULL
DS	NULL
,	NULL
Winestock	NULL
KD	NULL
:	NULL
IL-10	NULL
induces	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
tyk2	NULL
and	NULL
Jak1	NULL
and	NULL
the	NULL
differential	NULL
assembly	NULL
of	NULL
STATla	NULL
and	NULL
STAT3	NULL
complexes	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
monocytes	NULL
.	NULL

J	NULL
Immunol	NULL
155:1079	NULL
,	NULL
1995	NULL
19	NULL
.	NULL

Fu	NULL
X-Y	NULL
,	NULL
Schindler	NULL
C	NULL
,	NULL
Improta	NULL
T	NULL
,	NULL
Aebersold	NULL
R	NULL
,	NULL
Darnell	NULL
JE	NULL
Jr	NULL
:	NULL
The	NULL
proteins	NULL
of	NULL
ISGF-3	NULL
,	NULL
the	NULL
interferon	NULL
«	NULL
-induced	NULL
transcriptional	NULL
activator	NULL
,	NULL
define	NULL
a	NULL
gene	NULL
family	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:7840	NULL
,	NULL
1992	NULL
ROSEN	NULL
ET	NULL
AL	NULL
20	NULL
.	NULL

Azam	NULL
M	NULL
,	NULL
Erdjument-Bromage	NULL
H	NULL
,	NULL
Kreider	NULL
BL	NULL
,	NULL
Xia	NULL
M	NULL
,	NULL
Quelle	NULL
F	NULL
,	NULL
Basu	NULL
R	NULL
,	NULL
Saris	NULL
C	NULL
,	NULL
Tempst	NULL
P	NULL
,	NULL
Thie	NULL
JN	NULL
,	NULL
Schindler	NULL
C	NULL
:	NULL
Interleukin-3	NULL
signals	NULL
through	NULL
multiple	NULL
isoforms	NULL
of	NULL
STATS	NULL
.	NULL

EMBO	NULL
J	NULL
14:1402	NULL
,	NULL
1995	NULL
21	NULL
.	NULL

Johnston	NULL
JA	NULL
,	NULL
Bacon	NULL
CM	NULL
,	NULL
Finbloom	NULL
DS	NULL
,	NULL
Rees	NULL
RC	NULL
,	NULL
Kaplan	NULL
D	NULL
,	NULL
Shibuya	NULL
K	NULL
,	NULL
Ortaldo	NULL
JR	NULL
,	NULL
Gupta	NULL
S	NULL
,	NULL
Chen	NULL
YQ	NULL
,	NULL
Giri	NULL
JD	NULL
,	NULL
O'Shea	NULL
JJ	NULL
:	NULL
Tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
STATS	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
Janus	NULL
kinases	NULL
by	NULL
interleukins	NULL
2	NULL
and	NULL
15	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:8705	NULL
,	NULL
1995	NULL
22	NULL
.	NULL

Hou	NULL
J	NULL
,	NULL
Schindler	NULL
U	NULL
,	NULL
Henzel	NULL
WJ	NULL
,	NULL
Wong	NULL
SC	NULL
,	NULL
McKnight	NULL
SL	NULL
:	NULL
Identification	NULL
and	NULL
purification	NULL
of	NULL
human	NULL
Stat	NULL
proteins	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
.	NULL

Immunity	NULL
2:321	NULL
,	NULL
1995	NULL
23	NULL
.	NULL

Eilers	NULL
A	NULL
,	NULL
Baccarin	NULL
M	NULL
,	NULL
Horn	NULL
F	NULL
,	NULL
Hipskind	NULL
RA	NULL
,	NULL
Schindler	NULL
C	NULL
,	NULL
Decker	NULL
T	NULL
:	NULL
A	NULL
factor	NULL
induced	NULL
by	NULL
differentiation	NULL
signals	NULL
of	NULL
the	NULL
macrophage	NULL
lineage	NULL
binds	NULL
to	NULL
the	NULL
gamma	NULL
interferon	NULL
activation	NULL
site	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:1364	NULL
,	NULL
1994	NULL
24	NULL
.	NULL

Zhang	NULL
X	NULL
,	NULL
Blenis	NULL
J	NULL
,	NULL
Li	NULL
H-C	NULL
,	NULL
Schindler	NULL
C	NULL
,	NULL
Chen-Kiang	NULL
S	NULL
:	NULL
Requirement	NULL
of	NULL
serine	NULL
phosphorylation	NULL
for	NULL
formation	NULL
of	NULL
STAT-pro-moter	NULL
complexes	NULL
.	NULL

Science	NULL
267:1900	NULL
,	NULL
1995	NULL
25	NULL
.	NULL

Wen	NULL
Z	NULL
,	NULL
Zhong	NULL
Z	NULL
,	NULL
Darnell	NULL
JE	NULL
Jr	NULL
:	NULL
Maximal	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
STAT1	NULL
and	NULL
STAT3	NULL
requires	NULL
both	NULL
tyrosine	NULL
and	NULL
serine	NULL
phosphorylation	NULL
.	NULL

Cell	NULL
§2:241	NULL
,	NULL
1995	NULL
26	NULL
.	NULL

Bendall	NULL
LJ	NULL
,	NULL
Kortlepel	NULL
K	NULL
,	NULL
Gottlieb	NULL
DJ	NULL
:	NULL
GM-CSF	NULL
enhances	NULL
IL-2Z-activated	NULL
natural	NULL
killer	NULL
cell	NULL
lysis	NULL
of	NULL
clonogenic	NULL
AML	NULL
cells	NULL
by	NULL
upregulating	NULL
target	NULL
cell	NULL
expression	NULL
of	NULL
ICAM-1	NULL
.	NULL

Leukemia	NULL
9:677	NULL
,	NULL
1995	NULL
27	NULL
.	NULL

Semnani	NULL
RT	NULL
,	NULL
Nutman	NULL
TB	NULL
,	NULL
Hochman	NULL
P	NULL
,	NULL
Shaw	NULL
S	NULL
,	NULL
van	NULL
Seventer	NULL
GA	NULL
:	NULL
Costimulation	NULL
by	NULL
purified	NULL
intercellular	NULL
adhesion	NULL
molecule	NULL
1	NULL
and	NULL
lymphocyte	NULL
function-associated	NULL
antigen	NULL
3	NULL
induces	NULL
distinct	NULL
prolifera-tion	NULL
,	NULL
cytokine	NULL
and	NULL
cell	NULL
surface	NULL
antigen	NULL
profiles	NULL
in	NULL
human	NULL
naive	NULL
and	NULL
memory	NULL
CD4+	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
180:2125	NULL
,	NULL
1994	NULL
28	NULL
.	NULL

Hallek	NULL
M	NULL
,	NULL
Lepisto	NULL
EM	NULL
,	NULL
Slattery	NULL
KE	NULL
,	NULL
Griffin	NULL
JD	NULL
,	NULL
Emst	NULL
TJ	NULL
:	NULL
Interferon-y	NULL
increases	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
#	NULL
subunit	NULL
of	NULL
the	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
re-ceptor	NULL
.	NULL

Blood	NULL
80:1736	NULL
,	NULL
1992	NULL
29	NULL
.	NULL

Finbloom	NULL
DS	NULL
,	NULL
Larner	NULL
AC	NULL
,	NULL
Nakagawa	NULL
Y	NULL
,	NULL
Hoover	NULL
DL	NULL
:	NULL
Culture	NULL
of	NULL
human	NULL
monocytes	NULL
in	NULL
granulocyte-macrophage	NULL
CSF	NULL
results	NULL
in	NULL
enhancement	NULL
of	NULL
interferong	NULL
receptors	NULL
but	NULL
suppression	NULL
of	NULL
IFNy-induced	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
,	NULL
IP-10	NULL
.	NULL

J	NULL
Immunol	NULL
150:2383	NULL
,	NULL
1993	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blOOd	NULL
1996	NULL
88	NULL
:	NULL
1206-1214	NULL
Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
preferentially	NULL
activates	NULL
the	NULL
94-kD	NULL
STAT5A	NULL
and	NULL
an	NULL
80-kD	NULL
STAT5A	NULL
isoform	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
RL	NULL
Rosen	NULL
,	NULL
KD	NULL
Winestock	NULL
,	NULL
G	NULL
Chen	NULL
,	NULL
X	NULL
Liu	NULL
,	NULL
L	NULL
Hennighausen	NULL
and	NULL
DS	NULL
Finbloom	NULL
A	NULL
_	NULL
G	NULL
,	NULL
%	NULL
p	NULL
'	NULL
¢	NULL
\se	NULL
@	NULL
.	NULL

@	NULL
``	NULL
Q1oNT	NULL
(	NULL
f	NULL
@	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/88/4/1206.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

